id	sid	tid	token	lemma	pos
aiua-10985	1	1	stesura	stesura	PROPN
aiua-10985	1	2	seveso	seveso	NOUN
aiua-10985	1	3	521archivio	521archivio	PROPN
aiua-10985	1	4	italiano	italiano	NOUN
aiua-10985	1	5	di	di	NOUN
aiua-10985	1	6	urologia	urologia	PROPN
aiua-10985	1	7	e	e	PROPN
aiua-10985	1	8	andrologia	andrologia	PROPN
aiua-10985	1	9	2022	2022	NUM
aiua-10985	1	10	;	;	PUNCT
aiua-10985	1	11	94	94	NUM
aiua-10985	1	12	,	,	PUNCT
aiua-10985	1	13	4	4	NUM
aiua-10985	1	14	letter	letter	NOUN
aiua-10985	1	15	to	to	PART
aiua-10985	1	16	editor	editor	VERB
aiua-10985	1	17	no	no	DET
aiua-10985	1	18	conflict	conflict	NOUN
aiua-10985	1	19	of	of	ADP
aiua-10985	1	20	interest	interest	NOUN
aiua-10985	1	21	declared	declare	VERB
aiua-10985	1	22	.	.	PUNCT
aiua-10985	2	1	key	key	ADJ
aiua-10985	2	2	words	word	NOUN
aiua-10985	2	3	:	:	PUNCT
aiua-10985	2	4	benign	benign	ADJ
aiua-10985	2	5	prostatic	prostatic	ADJ
aiua-10985	2	6	hypertrophy	hypertrophy	NOUN
aiua-10985	2	7	;	;	PUNCT
aiua-10985	2	8	nocturia	nocturia	NOUN
aiua-10985	2	9	;	;	PUNCT
aiua-10985	2	10	discontinuation	discontinuation	NOUN
aiua-10985	2	11	;	;	PUNCT
aiua-10985	2	12	5	5	NUM
aiua-10985	2	13	-	-	PUNCT
aiua-10985	2	14	alpha	alpha	ADJ
aiua-10985	2	15	reductase	reductase	NOUN
aiua-10985	2	16	inhibitor	inhibitor	NOUN
aiua-10985	2	17	;	;	PUNCT
aiua-10985	2	18	polypharmacy	polypharmacy	NOUN
aiua-10985	2	19	.	.	PUNCT
aiua-10985	2	20	submitted	submit	VERB
aiua-10985	2	21	30	30	NUM
aiua-10985	2	22	october	october	NOUN
aiua-10985	2	23	2022	2022	NUM
aiua-10985	2	24	;	;	PUNCT
aiua-10985	2	25	accepted	accept	VERB
aiua-10985	2	26	19	19	NUM
aiua-10985	2	27	november	november	PROPN
aiua-10985	2	28	2022	2022	NUM
aiua-10985	2	29	to	to	ADP
aiua-10985	2	30	the	the	DET
aiua-10985	2	31	editor	editor	NOUN
aiua-10985	2	32	,	,	PUNCT
aiua-10985	2	33	benign	benign	ADJ
aiua-10985	2	34	prostatic	prostatic	ADJ
aiua-10985	2	35	hyperplasia	hyperplasia	NOUN
aiua-10985	2	36	(	(	PUNCT
aiua-10985	2	37	bph	bph	NOUN
aiua-10985	2	38	)	)	PUNCT
aiua-10985	2	39	is	be	AUX
aiua-10985	2	40	a	a	DET
aiua-10985	2	41	common	common	ADJ
aiua-10985	2	42	cause	cause	NOUN
aiua-10985	2	43	of	of	ADP
aiua-10985	2	44	lower	low	ADJ
aiua-10985	2	45	urinary	urinary	ADJ
aiua-10985	2	46	tract	tract	NOUN
aiua-10985	2	47	symptoms	symptom	NOUN
aiua-10985	2	48	(	(	PUNCT
aiua-10985	2	49	luts	luts	PROPN
aiua-10985	2	50	)	)	PUNCT
aiua-10985	2	51	in	in	ADP
aiua-10985	2	52	elderly	elderly	ADJ
aiua-10985	2	53	males	male	NOUN
aiua-10985	2	54	.	.	PUNCT
aiua-10985	3	1	the	the	DET
aiua-10985	3	2	current	current	ADJ
aiua-10985	3	3	guidelines	guideline	NOUN
aiua-10985	3	4	recommend	recommend	VERB
aiua-10985	3	5	the	the	DET
aiua-10985	3	6	use	use	NOUN
aiua-10985	3	7	of	of	ADP
aiua-10985	3	8	a	a	DET
aiua-10985	3	9	5	5	NUM
aiua-10985	3	10	-	-	PUNCT
aiua-10985	3	11	alpha	alpha	NOUN
aiua-10985	3	12	reductase	reductase	NOUN
aiua-10985	3	13	inhibitor	inhibitor	NOUN
aiua-10985	3	14	(	(	PUNCT
aiua-10985	3	15	5ari	5ari	PROPN
aiua-10985	3	16	)	)	PUNCT
aiua-10985	3	17	to	to	PART
aiua-10985	3	18	treat	treat	VERB
aiua-10985	3	19	males	male	NOUN
aiua-10985	3	20	with	with	ADP
aiua-10985	3	21	moderate	moderate	ADJ
aiua-10985	3	22	-	-	PUNCT
aiua-10985	3	23	to	to	ADP
aiua-10985	3	24	-	-	PUNCT
aiua-10985	3	25	severe	severe	ADJ
aiua-10985	3	26	luts	luts	PROPN
aiua-10985	3	27	and	and	CCONJ
aiua-10985	3	28	an	an	DET
aiua-10985	3	29	enlarged	enlarged	ADJ
aiua-10985	3	30	prostate	prostate	NOUN
aiua-10985	3	31	(	(	PUNCT
aiua-10985	3	32	1	1	NUM
aiua-10985	3	33	)	)	PUNCT
aiua-10985	3	34	.	.	PUNCT
aiua-10985	4	1	combination	combination	NOUN
aiua-10985	4	2	therapy	therapy	NOUN
aiua-10985	4	3	with	with	ADP
aiua-10985	4	4	an	an	DET
aiua-10985	4	5	alpha	alpha	NOUN
aiua-10985	4	6	blocker	blocker	NOUN
aiua-10985	4	7	and	and	CCONJ
aiua-10985	4	8	a	a	DET
aiua-10985	4	9	5ari	5ari	PROPN
aiua-10985	4	10	has	have	AUX
aiua-10985	4	11	proven	prove	VERB
aiua-10985	4	12	effective	effective	ADJ
aiua-10985	4	13	at	at	ADP
aiua-10985	4	14	ameliorating	ameliorate	VERB
aiua-10985	4	15	luts	luts	PROPN
aiua-10985	4	16	and	and	CCONJ
aiua-10985	4	17	reducing	reduce	VERB
aiua-10985	4	18	the	the	DET
aiua-10985	4	19	total	total	ADJ
aiua-10985	4	20	prostate	prostate	NOUN
aiua-10985	4	21	volume	volume	NOUN
aiua-10985	4	22	(	(	PUNCT
aiua-10985	4	23	tpv	tpv	PROPN
aiua-10985	4	24	)	)	PUNCT
aiua-10985	4	25	and	and	CCONJ
aiua-10985	4	26	the	the	DET
aiua-10985	4	27	risk	risk	NOUN
aiua-10985	4	28	of	of	ADP
aiua-10985	4	29	the	the	DET
aiua-10985	4	30	disease	disease	NOUN
aiua-10985	4	31	progression	progression	NOUN
aiua-10985	4	32	(	(	PUNCT
aiua-10985	4	33	2	2	NUM
aiua-10985	4	34	-	-	SYM
aiua-10985	4	35	5	5	NUM
aiua-10985	4	36	)	)	PUNCT
aiua-10985	4	37	.	.	PUNCT
aiua-10985	5	1	with	with	ADP
aiua-10985	5	2	the	the	DET
aiua-10985	5	3	aging	aging	NOUN
aiua-10985	5	4	of	of	ADP
aiua-10985	5	5	the	the	DET
aiua-10985	5	6	japanese	japanese	ADJ
aiua-10985	5	7	population	population	NOUN
aiua-10985	5	8	,	,	PUNCT
aiua-10985	5	9	it	it	PRON
aiua-10985	5	10	is	be	AUX
aiua-10985	5	11	expected	expect	VERB
aiua-10985	5	12	that	that	SCONJ
aiua-10985	5	13	the	the	DET
aiua-10985	5	14	frequencies	frequency	NOUN
aiua-10985	5	15	of	of	ADP
aiua-10985	5	16	various	various	ADJ
aiua-10985	5	17	chronic	chronic	ADJ
aiua-10985	5	18	diseases	disease	NOUN
aiua-10985	5	19	will	will	AUX
aiua-10985	5	20	increase	increase	VERB
aiua-10985	5	21	,	,	PUNCT
aiua-10985	5	22	and	and	CCONJ
aiua-10985	5	23	as	as	ADP
aiua-10985	5	24	a	a	DET
aiua-10985	5	25	result	result	NOUN
aiua-10985	5	26	,	,	PUNCT
aiua-10985	5	27	it	it	PRON
aiua-10985	5	28	is	be	AUX
aiua-10985	5	29	assumed	assume	VERB
aiua-10985	5	30	that	that	SCONJ
aiua-10985	5	31	the	the	DET
aiua-10985	5	32	number	number	NOUN
aiua-10985	5	33	of	of	ADP
aiua-10985	5	34	oral	oral	ADJ
aiua-10985	5	35	medications	medication	NOUN
aiua-10985	5	36	being	be	AUX
aiua-10985	5	37	taken	take	VERB
aiua-10985	5	38	by	by	ADP
aiua-10985	5	39	older	old	ADJ
aiua-10985	5	40	people	people	NOUN
aiua-10985	5	41	will	will	AUX
aiua-10985	5	42	rise	rise	VERB
aiua-10985	5	43	.	.	PUNCT
aiua-10985	6	1	it	it	PRON
aiua-10985	6	2	has	have	AUX
aiua-10985	6	3	been	be	AUX
aiua-10985	6	4	reported	report	VERB
aiua-10985	6	5	that	that	SCONJ
aiua-10985	6	6	the	the	DET
aiua-10985	6	7	incidence	incidence	NOUN
aiua-10985	6	8	of	of	ADP
aiua-10985	6	9	adverse	adverse	ADJ
aiua-10985	6	10	drug	drug	NOUN
aiua-10985	6	11	events	event	NOUN
aiua-10985	6	12	is	be	AUX
aiua-10985	6	13	higher	high	ADJ
aiua-10985	6	14	among	among	ADP
aiua-10985	6	15	the	the	DET
aiua-10985	6	16	elderly	elderly	ADJ
aiua-10985	6	17	than	than	ADP
aiua-10985	6	18	among	among	ADP
aiua-10985	6	19	younger	young	ADJ
aiua-10985	6	20	patients	patient	NOUN
aiua-10985	6	21	,	,	PUNCT
aiua-10985	6	22	and	and	CCONJ
aiua-10985	6	23	adverse	adverse	ADJ
aiua-10985	6	24	drug	drug	NOUN
aiua-10985	6	25	event	event	NOUN
aiua-10985	6	26	rates	rate	NOUN
aiua-10985	6	27	of	of	ADP
aiua-10985	6	28	15	15	NUM
aiua-10985	6	29	-	-	SYM
aiua-10985	6	30	20	20	NUM
aiua-10985	6	31	%	%	NOUN
aiua-10985	6	32	per	per	ADP
aiua-10985	6	33	year	year	NOUN
aiua-10985	6	34	have	have	AUX
aiua-10985	6	35	been	be	AUX
aiua-10985	6	36	reported	report	VERB
aiua-10985	6	37	in	in	ADP
aiua-10985	6	38	nursing	nursing	NOUN
aiua-10985	6	39	homes	home	NOUN
aiua-10985	6	40	in	in	ADP
aiua-10985	6	41	the	the	DET
aiua-10985	6	42	united	united	PROPN
aiua-10985	6	43	states	states	PROPN
aiua-10985	6	44	(	(	PUNCT
aiua-10985	6	45	6	6	NUM
aiua-10985	6	46	)	)	PUNCT
aiua-10985	6	47	.	.	PUNCT
aiua-10985	7	1	the	the	DET
aiua-10985	7	2	higher	high	ADJ
aiua-10985	7	3	adverse	adverse	ADJ
aiua-10985	7	4	drug	drug	NOUN
aiua-10985	7	5	event	event	NOUN
aiua-10985	7	6	rates	rate	NOUN
aiua-10985	7	7	seen	see	VERB
aiua-10985	7	8	in	in	ADP
aiua-10985	7	9	elderly	elderly	ADJ
aiua-10985	7	10	patients	patient	NOUN
aiua-10985	7	11	are	be	AUX
aiua-10985	7	12	caused	cause	VERB
aiua-10985	7	13	by	by	ADP
aiua-10985	7	14	greater	great	ADJ
aiua-10985	7	15	drug	drug	NOUN
aiua-10985	7	16	sensitivity	sensitivity	NOUN
aiua-10985	7	17	due	due	ADP
aiua-10985	7	18	to	to	ADP
aiua-10985	7	19	age	age	NOUN
aiua-10985	7	20	-	-	PUNCT
aiua-10985	7	21	related	relate	VERB
aiua-10985	7	22	changes	change	NOUN
aiua-10985	7	23	in	in	ADP
aiua-10985	7	24	pharmacokinetics	pharmacokinetic	NOUN
aiua-10985	7	25	and	and	CCONJ
aiua-10985	7	26	the	the	DET
aiua-10985	7	27	higher	high	ADJ
aiua-10985	7	28	number	number	NOUN
aiua-10985	7	29	of	of	ADP
aiua-10985	7	30	drugs	drug	NOUN
aiua-10985	7	31	being	be	AUX
aiua-10985	7	32	taken	take	VERB
aiua-10985	7	33	by	by	ADP
aiua-10985	7	34	each	each	DET
aiua-10985	7	35	patient	patient	NOUN
aiua-10985	7	36	.	.	PUNCT
aiua-10985	8	1	as	as	SCONJ
aiua-10985	8	2	mentioned	mention	VERB
aiua-10985	8	3	above	above	ADV
aiua-10985	8	4	,	,	PUNCT
aiua-10985	8	5	elderly	elderly	ADJ
aiua-10985	8	6	people	people	NOUN
aiua-10985	8	7	are	be	AUX
aiua-10985	8	8	prone	prone	ADJ
aiua-10985	8	9	to	to	ADP
aiua-10985	8	10	polypharmacy	polypharmacy	NOUN
aiua-10985	8	11	,	,	PUNCT
aiua-10985	8	12	as	as	SCONJ
aiua-10985	8	13	they	they	PRON
aiua-10985	8	14	have	have	VERB
aiua-10985	8	15	many	many	ADJ
aiua-10985	8	16	comorbidities	comorbiditie	NOUN
aiua-10985	8	17	.	.	PUNCT
aiua-10985	9	1	in	in	ADP
aiua-10985	9	2	a	a	DET
aiua-10985	9	3	multicenter	multicenter	ADJ
aiua-10985	9	4	study	study	NOUN
aiua-10985	9	5	,	,	PUNCT
aiua-10985	9	6	it	it	PRON
aiua-10985	9	7	was	be	AUX
aiua-10985	9	8	reported	report	VERB
aiua-10985	9	9	that	that	SCONJ
aiua-10985	9	10	the	the	DET
aiua-10985	9	11	elderly	elderly	ADJ
aiua-10985	9	12	subjects	subject	NOUN
aiua-10985	9	13	were	be	AUX
aiua-10985	9	14	taking	take	VERB
aiua-10985	9	15	an	an	DET
aiua-10985	9	16	average	average	NOUN
aiua-10985	9	17	of	of	ADP
aiua-10985	9	18	4.5	4.5	NUM
aiua-10985	9	19	different	different	ADJ
aiua-10985	9	20	medications	medication	NOUN
aiua-10985	9	21	(	(	PUNCT
aiua-10985	9	22	7	7	NUM
aiua-10985	9	23	)	)	PUNCT
aiua-10985	9	24	.	.	PUNCT
aiua-10985	10	1	polypharmacy	polypharmacy	NOUN
aiua-10985	10	2	is	be	AUX
aiua-10985	10	3	associated	associate	VERB
aiua-10985	10	4	with	with	ADP
aiua-10985	10	5	increases	increase	NOUN
aiua-10985	10	6	in	in	ADP
aiua-10985	10	7	drug	drug	NOUN
aiua-10985	10	8	costs	cost	NOUN
aiua-10985	10	9	and	and	CCONJ
aiua-10985	10	10	drug	drug	NOUN
aiua-10985	10	11	interactions	interaction	NOUN
aiua-10985	10	12	.	.	PUNCT
aiua-10985	11	1	in	in	ADP
aiua-10985	11	2	addition	addition	NOUN
aiua-10985	11	3	,	,	PUNCT
aiua-10985	11	4	it	it	PRON
aiua-10985	11	5	has	have	AUX
aiua-10985	11	6	been	be	AUX
aiua-10985	11	7	reported	report	VERB
aiua-10985	11	8	that	that	SCONJ
aiua-10985	11	9	the	the	DET
aiua-10985	11	10	risk	risk	NOUN
aiua-10985	11	11	of	of	ADP
aiua-10985	11	12	adverse	adverse	ADJ
aiua-10985	11	13	drug	drug	NOUN
aiua-10985	11	14	events	event	NOUN
aiua-10985	11	15	was	be	AUX
aiua-10985	11	16	increased	increase	VERB
aiua-10985	11	17	in	in	ADP
aiua-10985	11	18	patients	patient	NOUN
aiua-10985	11	19	taking	take	VERB
aiua-10985	11	20	≥	≥	NOUN
aiua-10985	11	21	6	6	NUM
aiua-10985	11	22	drugs	drug	NOUN
aiua-10985	11	23	(	(	PUNCT
aiua-10985	11	24	8)	8)	NUM
aiua-10985	11	25	,	,	PUNCT
aiua-10985	11	26	and	and	CCONJ
aiua-10985	11	27	furthermore	furthermore	ADV
aiua-10985	11	28	,	,	PUNCT
aiua-10985	11	29	that	that	SCONJ
aiua-10985	11	30	the	the	DET
aiua-10985	11	31	incidence	incidence	NOUN
aiua-10985	11	32	of	of	ADP
aiua-10985	11	33	falls	fall	NOUN
aiua-10985	11	34	was	be	AUX
aiua-10985	11	35	high	high	ADJ
aiua-10985	11	36	among	among	ADP
aiua-10985	11	37	patients	patient	NOUN
aiua-10985	11	38	taking	take	VERB
aiua-10985	11	39	≥	≥	NOUN
aiua-10985	11	40	5	5	NUM
aiua-10985	11	41	drugs	drug	NOUN
aiua-10985	11	42	(	(	PUNCT
aiua-10985	11	43	9	9	NUM
aiua-10985	11	44	)	)	PUNCT
aiua-10985	11	45	.	.	PUNCT
aiua-10985	12	1	therefore	therefore	ADV
aiua-10985	12	2	,	,	PUNCT
aiua-10985	12	3	among	among	ADP
aiua-10985	12	4	elderly	elderly	ADJ
aiua-10985	12	5	people	people	NOUN
aiua-10985	12	6	,	,	PUNCT
aiua-10985	12	7	even	even	ADV
aiua-10985	12	8	if	if	SCONJ
aiua-10985	12	9	only	only	ADV
aiua-10985	12	10	one	one	NUM
aiua-10985	12	11	type	type	NOUN
aiua-10985	12	12	of	of	ADP
aiua-10985	12	13	medication	medication	NOUN
aiua-10985	12	14	is	be	AUX
aiua-10985	12	15	discontinued	discontinue	VERB
aiua-10985	12	16	,	,	PUNCT
aiua-10985	12	17	the	the	DET
aiua-10985	12	18	risk	risk	NOUN
aiua-10985	12	19	of	of	ADP
aiua-10985	12	20	adverse	adverse	ADJ
aiua-10985	12	21	drug	drug	NOUN
aiua-10985	12	22	events	event	NOUN
aiua-10985	12	23	can	can	AUX
aiua-10985	12	24	be	be	AUX
aiua-10985	12	25	expected	expect	VERB
aiua-10985	12	26	to	to	PART
aiua-10985	12	27	decrease	decrease	VERB
aiua-10985	12	28	,	,	PUNCT
aiua-10985	12	29	which	which	PRON
aiua-10985	12	30	may	may	AUX
aiua-10985	12	31	help	help	VERB
aiua-10985	12	32	to	to	PART
aiua-10985	12	33	reduce	reduce	VERB
aiua-10985	12	34	healthcare	healthcare	NOUN
aiua-10985	12	35	costs	cost	NOUN
aiua-10985	12	36	in	in	ADP
aiua-10985	12	37	the	the	DET
aiua-10985	12	38	long	long	ADJ
aiua-10985	12	39	term	term	NOUN
aiua-10985	12	40	.	.	PUNCT
aiua-10985	13	1	it	it	PRON
aiua-10985	13	2	has	have	AUX
aiua-10985	13	3	been	be	AUX
aiua-10985	13	4	reported	report	VERB
aiua-10985	13	5	that	that	SCONJ
aiua-10985	13	6	when	when	SCONJ
aiua-10985	13	7	an	an	DET
aiua-10985	13	8	alpha-1	alpha-1	PROPN
aiua-10985	13	9	blocker	blocker	NOUN
aiua-10985	13	10	is	be	AUX
aiua-10985	13	11	combined	combine	VERB
aiua-10985	13	12	with	with	ADP
aiua-10985	13	13	dutasteride	dutasteride	NOUN
aiua-10985	13	14	,	,	PUNCT
aiua-10985	13	15	symptom	symptom	NOUN
aiua-10985	13	16	relief	relief	NOUN
aiua-10985	13	17	can	can	AUX
aiua-10985	13	18	be	be	AUX
aiua-10985	13	19	maintained	maintain	VERB
aiua-10985	13	20	with	with	ADP
aiua-10985	13	21	dutasteride	dutasteride	NOUN
aiua-10985	13	22	alone	alone	ADV
aiua-10985	13	23	after	after	ADP
aiua-10985	13	24	the	the	DET
aiua-10985	13	25	discontinuation	discontinuation	NOUN
aiua-10985	13	26	of	of	ADP
aiua-10985	13	27	the	the	DET
aiua-10985	13	28	alpha-1	alpha-1	PROPN
aiua-10985	13	29	blocker	blocker	NOUN
aiua-10985	13	30	(	(	PUNCT
aiua-10985	13	31	10	10	NUM
aiua-10985	13	32	)	)	PUNCT
aiua-10985	13	33	.	.	PUNCT
aiua-10985	14	1	however	however	ADV
aiua-10985	14	2	,	,	PUNCT
aiua-10985	14	3	it	it	PRON
aiua-10985	14	4	has	have	AUX
aiua-10985	14	5	also	also	ADV
aiua-10985	14	6	been	be	AUX
aiua-10985	14	7	reported	report	VERB
aiua-10985	14	8	that	that	SCONJ
aiua-10985	14	9	60	60	NUM
aiua-10985	14	10	%	%	NOUN
aiua-10985	14	11	of	of	ADP
aiua-10985	14	12	patients	patient	NOUN
aiua-10985	14	13	who	who	PRON
aiua-10985	14	14	stop	stop	VERB
aiua-10985	14	15	taking	take	VERB
aiua-10985	14	16	dutasteride	dutasteride	NOUN
aiua-10985	14	17	resume	resume	NOUN
aiua-10985	14	18	taking	take	VERB
aiua-10985	14	19	it	it	PRON
aiua-10985	14	20	within	within	ADP
aiua-10985	14	21	1	1	NUM
aiua-10985	14	22	year	year	NOUN
aiua-10985	14	23	(	(	PUNCT
aiua-10985	14	24	11	11	NUM
aiua-10985	14	25	)	)	PUNCT
aiua-10985	14	26	.	.	PUNCT
aiua-10985	15	1	recently	recently	ADV
aiua-10985	15	2	,	,	PUNCT
aiua-10985	15	3	it	it	PRON
aiua-10985	15	4	was	be	AUX
aiua-10985	15	5	suggested	suggest	VERB
aiua-10985	15	6	that	that	SCONJ
aiua-10985	15	7	5ari	5ari	PROPN
aiua-10985	15	8	may	may	AUX
aiua-10985	15	9	induce	induce	VERB
aiua-10985	15	10	suicidal	suicidal	ADJ
aiua-10985	15	11	behavior	behavior	NOUN
aiua-10985	15	12	and	and	CCONJ
aiua-10985	15	13	depression	depression	NOUN
aiua-10985	15	14	and	and	CCONJ
aiua-10985	15	15	that	that	SCONJ
aiua-10985	15	16	the	the	DET
aiua-10985	15	17	discontinuation	discontinuation	NOUN
aiua-10985	15	18	of	of	ADP
aiua-10985	15	19	5ari	5ari	PROPN
aiua-10985	15	20	should	should	AUX
aiua-10985	15	21	be	be	AUX
aiua-10985	15	22	considered	consider	VERB
aiua-10985	15	23	(	(	PUNCT
aiua-10985	15	24	12	12	NUM
aiua-10985	15	25	)	)	PUNCT
aiua-10985	15	26	.	.	PUNCT
aiua-10985	16	1	however	however	ADV
aiua-10985	16	2	,	,	PUNCT
aiua-10985	16	3	there	there	PRON
aiua-10985	16	4	are	be	VERB
aiua-10985	16	5	no	no	DET
aiua-10985	16	6	studies	study	NOUN
aiua-10985	16	7	involving	involve	VERB
aiua-10985	16	8	a	a	DET
aiua-10985	16	9	follow	follow	VERB
aiua-10985	16	10	-	-	PUNCT
aiua-10985	16	11	up	up	NOUN
aiua-10985	16	12	period	period	NOUN
aiua-10985	16	13	of	of	ADP
aiua-10985	16	14	2	2	NUM
aiua-10985	16	15	years	year	NOUN
aiua-10985	16	16	after	after	ADP
aiua-10985	16	17	discontinuation	discontinuation	NOUN
aiua-10985	16	18	of	of	ADP
aiua-10985	16	19	dutasteride	dutasteride	NOUN
aiua-10985	16	20	.	.	PUNCT
aiua-10985	17	1	the	the	DET
aiua-10985	17	2	purpose	purpose	NOUN
aiua-10985	17	3	of	of	ADP
aiua-10985	17	4	this	this	DET
aiua-10985	17	5	study	study	NOUN
aiua-10985	17	6	was	be	AUX
aiua-10985	17	7	to	to	PART
aiua-10985	17	8	investigate	investigate	VERB
aiua-10985	17	9	the	the	DET
aiua-10985	17	10	predictors	predictor	NOUN
aiua-10985	17	11	of	of	ADP
aiua-10985	17	12	restarting	restart	VERB
aiua-10985	17	13	dutasteride	dutasteride	NOUN
aiua-10985	17	14	in	in	ADP
aiua-10985	17	15	a	a	DET
aiua-10985	17	16	real	real	ADJ
aiua-10985	17	17	-	-	PUNCT
aiua-10985	17	18	world	world	NOUN
aiua-10985	17	19	setting	setting	NOUN
aiua-10985	17	20	in	in	ADP
aiua-10985	17	21	the	the	DET
aiua-10985	17	22	era	era	NOUN
aiua-10985	17	23	of	of	ADP
aiua-10985	17	24	polypharmacy	polypharmacy	NOUN
aiua-10985	17	25	.	.	PUNCT
aiua-10985	18	1	at	at	ADP
aiua-10985	18	2	the	the	DET
aiua-10985	18	3	beginning	beginning	NOUN
aiua-10985	18	4	of	of	ADP
aiua-10985	18	5	2016	2016	NUM
aiua-10985	18	6	a	a	DET
aiua-10985	18	7	shortage	shortage	NOUN
aiua-10985	18	8	of	of	ADP
aiua-10985	18	9	the	the	DET
aiua-10985	18	10	drug	drug	NOUN
aiua-10985	18	11	forced	force	VERB
aiua-10985	18	12	us	we	PRON
aiua-10985	18	13	to	to	PART
aiua-10985	18	14	stop	stop	VERB
aiua-10985	18	15	dutasteride	dutasteride	NOUN
aiua-10985	18	16	treatment	treatment	NOUN
aiua-10985	18	17	in	in	ADP
aiua-10985	18	18	a	a	DET
aiua-10985	18	19	group	group	NOUN
aiua-10985	18	20	of	of	ADP
aiua-10985	18	21	patients	patient	NOUN
aiua-10985	18	22	.	.	PUNCT
aiua-10985	19	1	the	the	DET
aiua-10985	19	2	drug	drug	NOUN
aiua-10985	19	3	returned	return	VERB
aiua-10985	19	4	to	to	PART
aiua-10985	19	5	be	be	AUX
aiua-10985	19	6	available	available	ADJ
aiua-10985	19	7	after	after	ADP
aiua-10985	19	8	four	four	NUM
aiua-10985	19	9	months	month	NOUN
aiua-10985	19	10	.	.	PUNCT
aiua-10985	20	1	nevertheless	nevertheless	ADV
aiua-10985	20	2	,	,	PUNCT
aiua-10985	20	3	some	some	DET
aiua-10985	20	4	patients	patient	NOUN
aiua-10985	20	5	did	do	AUX
aiua-10985	20	6	not	not	PART
aiua-10985	20	7	restart	restart	VERB
aiua-10985	20	8	dutasteride	dutasteride	ADV
aiua-10985	20	9	but	but	CCONJ
aiua-10985	20	10	remained	remain	VERB
aiua-10985	20	11	on	on	ADP
aiua-10985	20	12	treatment	treatment	NOUN
aiua-10985	20	13	with	with	ADP
aiua-10985	20	14	alpha	alpha	NOUN
aiua-10985	20	15	-	-	PUNCT
aiua-10985	20	16	blockers	blocker	NOUN
aiua-10985	20	17	alone	alone	ADV
aiua-10985	20	18	.	.	PUNCT
aiua-10985	21	1	we	we	PRON
aiua-10985	21	2	aimed	aim	VERB
aiua-10985	21	3	to	to	PART
aiua-10985	21	4	evaluate	evaluate	VERB
aiua-10985	21	5	reasons	reason	NOUN
aiua-10985	21	6	for	for	ADP
aiua-10985	21	7	restarting	restart	VERB
aiua-10985	21	8	or	or	CCONJ
aiua-10985	21	9	not	not	PART
aiua-10985	21	10	dutasteride	dutasteride	VERB
aiua-10985	21	11	after	after	ADP
aiua-10985	21	12	a	a	DET
aiua-10985	21	13	period	period	NOUN
aiua-10985	21	14	of	of	ADP
aiua-10985	21	15	discontinuation	discontinuation	NOUN
aiua-10985	21	16	.	.	PUNCT
aiua-10985	22	1	material	material	NOUN
aiua-10985	22	2	and	and	CCONJ
aiua-10985	22	3	methods	method	NOUN
aiua-10985	22	4	study	study	NOUN
aiua-10985	22	5	subjects	subject	NOUN
aiua-10985	22	6	we	we	PRON
aiua-10985	22	7	retrospectively	retrospectively	ADV
aiua-10985	22	8	reviewed	review	VERB
aiua-10985	22	9	the	the	DET
aiua-10985	22	10	medical	medical	ADJ
aiua-10985	22	11	records	record	NOUN
aiua-10985	22	12	of	of	ADP
aiua-10985	22	13	patients	patient	NOUN
aiua-10985	22	14	with	with	ADP
aiua-10985	22	15	luts	luts	PROPN
aiua-10985	22	16	secondary	secondary	PROPN
aiua-10985	22	17	to	to	ADP
aiua-10985	22	18	bph	bph	NOUN
aiua-10985	22	19	who	who	PRON
aiua-10985	22	20	were	be	AUX
aiua-10985	22	21	treated	treat	VERB
aiua-10985	22	22	with	with	ADP
aiua-10985	22	23	an	an	DET
aiua-10985	22	24	alpha-1	alpha-1	NUM
aiua-10985	22	25	blocker	blocker	NOUN
aiua-10985	22	26	and	and	CCONJ
aiua-10985	22	27	dutasteride	dutasteride	NOUN
aiua-10985	22	28	(	(	PUNCT
aiua-10985	22	29	0.5	0.5	NUM
aiua-10985	22	30	mg	mg	PROPN
aiua-10985	22	31	/	/	SYM
aiua-10985	22	32	d	d	NOUN
aiua-10985	22	33	)	)	PUNCT
aiua-10985	22	34	from	from	ADP
aiua-10985	22	35	september	september	PROPN
aiua-10985	22	36	2010	2010	NUM
aiua-10985	22	37	to	to	ADP
aiua-10985	22	38	december	december	PROPN
aiua-10985	22	39	2015	2015	NUM
aiua-10985	22	40	.	.	PUNCT
aiua-10985	23	1	from	from	ADP
aiua-10985	23	2	january	january	PROPN
aiua-10985	23	3	2016	2016	NUM
aiua-10985	23	4	,	,	PUNCT
aiua-10985	23	5	dutasteride	dutasteride	PROPN
aiua-10985	23	6	was	be	AUX
aiua-10985	23	7	discontinued	discontinue	VERB
aiua-10985	23	8	,	,	PUNCT
aiua-10985	23	9	and	and	CCONJ
aiua-10985	23	10	the	the	DET
aiua-10985	23	11	patients	patient	NOUN
aiua-10985	23	12	were	be	AUX
aiua-10985	23	13	only	only	ADV
aiua-10985	23	14	prescribed	prescribe	VERB
aiua-10985	23	15	an	an	DET
aiua-10985	23	16	alpha-1	alpha-1	PROPN
aiua-10985	23	17	blocker	blocker	NOUN
aiua-10985	23	18	.	.	PUNCT
aiua-10985	24	1	a	a	DET
aiua-10985	24	2	total	total	NOUN
aiua-10985	24	3	of	of	ADP
aiua-10985	24	4	39	39	NUM
aiua-10985	24	5	patients	patient	NOUN
aiua-10985	24	6	were	be	AUX
aiua-10985	24	7	included	include	VERB
aiua-10985	24	8	in	in	ADP
aiua-10985	24	9	this	this	DET
aiua-10985	24	10	study	study	NOUN
aiua-10985	24	11	.	.	PUNCT
aiua-10985	25	1	the	the	DET
aiua-10985	25	2	patients	patient	NOUN
aiua-10985	25	3	were	be	AUX
aiua-10985	25	4	divided	divide	VERB
aiua-10985	25	5	into	into	ADP
aiua-10985	25	6	two	two	NUM
aiua-10985	25	7	groups	group	NOUN
aiua-10985	25	8	:	:	PUNCT
aiua-10985	25	9	patients	patient	NOUN
aiua-10985	25	10	who	who	PRON
aiua-10985	25	11	restarted	restart	VERB
aiua-10985	25	12	dutasteride	dutasteride	PROPN
aiua-10985	25	13	(	(	PUNCT
aiua-10985	25	14	dr	dr	PROPN
aiua-10985	25	15	)	)	PUNCT
aiua-10985	25	16	and	and	CCONJ
aiua-10985	25	17	patients	patient	NOUN
aiua-10985	25	18	who	who	PRON
aiua-10985	25	19	remained	remain	VERB
aiua-10985	25	20	on	on	ADP
aiua-10985	25	21	discontinuation	discontinuation	NOUN
aiua-10985	25	22	of	of	ADP
aiua-10985	25	23	dutasteride	dutasteride	NOUN
aiua-10985	25	24	(	(	PUNCT
aiua-10985	25	25	dd	dd	NOUN
aiua-10985	25	26	)	)	PUNCT
aiua-10985	25	27	group	group	NOUN
aiua-10985	25	28	.	.	PUNCT
aiua-10985	26	1	in	in	ADP
aiua-10985	26	2	both	both	DET
aiua-10985	26	3	groups	group	NOUN
aiua-10985	26	4	,	,	PUNCT
aiua-10985	26	5	age	age	NOUN
aiua-10985	26	6	,	,	PUNCT
aiua-10985	26	7	body	body	NOUN
aiua-10985	26	8	mass	mass	NOUN
aiua-10985	26	9	index	index	NOUN
aiua-10985	26	10	(	(	PUNCT
aiua-10985	26	11	bmi	bmi	PROPN
aiua-10985	26	12	)	)	PUNCT
aiua-10985	26	13	,	,	PUNCT
aiua-10985	26	14	international	international	ADJ
aiua-10985	26	15	prostate	prostate	NOUN
aiua-10985	26	16	symptom	symptom	NOUN
aiua-10985	26	17	score	score	NOUN
aiua-10985	26	18	(	(	PUNCT
aiua-10985	26	19	ipss	ipss	PROPN
aiua-10985	26	20	)	)	PUNCT
aiua-10985	26	21	,	,	PUNCT
aiua-10985	26	22	quality	quality	NOUN
aiua-10985	26	23	-	-	PUNCT
aiua-10985	26	24	of	of	ADP
aiua-10985	26	25	-	-	PUNCT
aiua-10985	26	26	life	life	NOUN
aiua-10985	26	27	(	(	PUNCT
aiua-10985	26	28	qol	qol	NOUN
aiua-10985	26	29	)	)	PUNCT
aiua-10985	26	30	score	score	NOUN
aiua-10985	26	31	,	,	PUNCT
aiua-10985	26	32	overactive	overactive	ADJ
aiua-10985	26	33	bladder	bladder	NOUN
aiua-10985	26	34	symptom	symptom	NOUN
aiua-10985	26	35	score	score	NOUN
aiua-10985	26	36	(	(	PUNCT
aiua-10985	26	37	oabss	oabss	NOUN
aiua-10985	26	38	)	)	PUNCT
aiua-10985	26	39	,	,	PUNCT
aiua-10985	26	40	duration	duration	NOUN
aiua-10985	26	41	of	of	ADP
aiua-10985	26	42	dutasteride	dutasteride	NOUN
aiua-10985	26	43	treatment	treatment	NOUN
aiua-10985	26	44	before	before	ADP
aiua-10985	26	45	outcomes	outcome	NOUN
aiua-10985	26	46	of	of	ADP
aiua-10985	26	47	dutasteride	dutasteride	NOUN
aiua-10985	26	48	discontinuation	discontinuation	NOUN
aiua-10985	26	49	in	in	ADP
aiua-10985	26	50	patients	patient	NOUN
aiua-10985	26	51	with	with	ADP
aiua-10985	26	52	benign	benign	ADJ
aiua-10985	26	53	prostatic	prostatic	ADJ
aiua-10985	26	54	hypertrophy	hypertrophy	NOUN
aiua-10985	26	55	hiroshi	hiroshi	PROPN
aiua-10985	26	56	masuda	masuda	PROPN
aiua-10985	26	57	,	,	PUNCT
aiua-10985	26	58	kosuke	kosuke	PROPN
aiua-10985	26	59	mikami	mikami	PROPN
aiua-10985	26	60	,	,	PUNCT
aiua-10985	26	61	kotaro	kotaro	PROPN
aiua-10985	26	62	otsuka	otsuka	PROPN
aiua-10985	26	63	,	,	PUNCT
aiua-10985	26	64	kyokusin	kyokusin	PROPN
aiua-10985	26	65	hou	hou	PROPN
aiua-10985	26	66	,	,	PUNCT
aiua-10985	26	67	takahito	takahito	NOUN
aiua-10985	26	68	suyama	suyama	NOUN
aiua-10985	26	69	,	,	PUNCT
aiua-10985	26	70	kazuhiro	kazuhiro	PROPN
aiua-10985	26	71	araki	araki	PROPN
aiua-10985	26	72	,	,	PUNCT
aiua-10985	26	73	satoko	satoko	PROPN
aiua-10985	26	74	kojima	kojima	PROPN
aiua-10985	26	75	,	,	PUNCT
aiua-10985	26	76	yukio	yukio	PROPN
aiua-10985	26	77	naya	naya	PROPN
aiua-10985	26	78	department	department	PROPN
aiua-10985	26	79	of	of	ADP
aiua-10985	26	80	urology	urology	NOUN
aiua-10985	26	81	,	,	PUNCT
aiua-10985	26	82	teikyo	teikyo	PROPN
aiua-10985	26	83	university	university	PROPN
aiua-10985	26	84	chiba	chiba	PROPN
aiua-10985	26	85	medical	medical	PROPN
aiua-10985	26	86	center	center	NOUN
aiua-10985	26	87	,	,	PUNCT
aiua-10985	26	88	3426	3426	NUM
aiua-10985	26	89	-	-	SYM
aiua-10985	26	90	3	3	NUM
aiua-10985	26	91	anesaki	anesaki	NOUN
aiua-10985	26	92	,	,	PUNCT
aiua-10985	26	93	ichihara	ichihara	PROPN
aiua-10985	26	94	,	,	PUNCT
aiua-10985	26	95	chiba	chiba	PROPN
aiua-10985	26	96	299	299	NUM
aiua-10985	26	97	-	-	SYM
aiua-10985	26	98	0111	0111	NUM
aiua-10985	26	99	,	,	PUNCT
aiua-10985	26	100	japan	japan	PROPN
aiua-10985	26	101	.	.	PUNCT
aiua-10985	26	102	doi	doi	PROPN
aiua-10985	26	103	:	:	PUNCT
aiua-10985	26	104	10.4081	10.4081	NUM
aiua-10985	26	105	/	/	SYM
aiua-10985	26	106	aiua.2022.4.521	aiua.2022.4.521	NOUN
aiua-10985	26	107	archivio	archivio	NOUN
aiua-10985	26	108	italiano	italiano	X
aiua-10985	26	109	di	di	X
aiua-10985	26	110	urologia	urologia	PROPN
aiua-10985	26	111	e	e	PROPN
aiua-10985	26	112	andrologia	andrologia	PROPN
aiua-10985	26	113	2022	2022	NUM
aiua-10985	26	114	;	;	PUNCT
aiua-10985	26	115	94	94	NUM
aiua-10985	26	116	,	,	PUNCT
aiua-10985	26	117	4	4	NUM
aiua-10985	26	118	h.	h.	PROPN
aiua-10985	26	119	masuda	masuda	PROPN
aiua-10985	26	120	,	,	PUNCT
aiua-10985	26	121	k.	k.	PROPN
aiua-10985	26	122	mikami	mikami	PROPN
aiua-10985	26	123	,	,	PUNCT
aiua-10985	26	124	k.	k.	PROPN
aiua-10985	26	125	otsuka	otsuka	PROPN
aiua-10985	26	126	,	,	PUNCT
aiua-10985	26	127	k.	k.	PROPN
aiua-10985	26	128	hou	hou	PROPN
aiua-10985	26	129	,	,	PUNCT
aiua-10985	26	130	t.	t.	NOUN
aiua-10985	26	131	suyama	suyama	NOUN
aiua-10985	26	132	,	,	PUNCT
aiua-10985	26	133	k.	k.	PROPN
aiua-10985	26	134	araki	araki	PROPN
aiua-10985	26	135	,	,	PUNCT
aiua-10985	26	136	s.	s.	PROPN
aiua-10985	26	137	kojima	kojima	PROPN
aiua-10985	26	138	,	,	PUNCT
aiua-10985	26	139	y.	y.	PROPN
aiua-10985	26	140	naya	naya	PROPN
aiua-10985	26	141	522	522	NUM
aiua-10985	26	142	discontinuation	discontinuation	NOUN
aiua-10985	26	143	,	,	PUNCT
aiua-10985	26	144	number	number	NOUN
aiua-10985	26	145	of	of	ADP
aiua-10985	26	146	different	different	ADJ
aiua-10985	26	147	types	type	NOUN
aiua-10985	26	148	of	of	ADP
aiua-10985	26	149	medications	medication	NOUN
aiua-10985	26	150	being	be	AUX
aiua-10985	26	151	taken	take	VERB
aiua-10985	26	152	by	by	ADP
aiua-10985	26	153	the	the	DET
aiua-10985	26	154	patients	patient	NOUN
aiua-10985	26	155	,	,	PUNCT
aiua-10985	26	156	prostate	prostate	NOUN
aiua-10985	26	157	volume	volume	NOUN
aiua-10985	26	158	,	,	PUNCT
aiua-10985	26	159	rate	rate	NOUN
aiua-10985	26	160	of	of	ADP
aiua-10985	26	161	reduction	reduction	NOUN
aiua-10985	26	162	in	in	ADP
aiua-10985	26	163	prostate	prostate	NOUN
aiua-10985	26	164	volume	volume	NOUN
aiua-10985	26	165	,	,	PUNCT
aiua-10985	26	166	post	post	ADJ
aiua-10985	26	167	-	-	ADJ
aiua-10985	26	168	void	void	ADJ
aiua-10985	26	169	residual	residual	ADJ
aiua-10985	26	170	volume	volume	NOUN
aiua-10985	26	171	(	(	PUNCT
aiua-10985	26	172	pvr	pvr	NOUN
aiua-10985	26	173	)	)	PUNCT
aiua-10985	26	174	,	,	PUNCT
aiua-10985	26	175	and	and	CCONJ
aiua-10985	26	176	presence	presence	NOUN
aiua-10985	26	177	or	or	CCONJ
aiua-10985	26	178	absence	absence	NOUN
aiua-10985	26	179	of	of	ADP
aiua-10985	26	180	comorbidities	comorbiditie	NOUN
aiua-10985	26	181	were	be	AUX
aiua-10985	26	182	evaluated	evaluate	VERB
aiua-10985	26	183	.	.	PUNCT
aiua-10985	27	1	prostate	prostate	NOUN
aiua-10985	27	2	volume	volume	NOUN
aiua-10985	27	3	and	and	CCONJ
aiua-10985	27	4	the	the	DET
aiua-10985	27	5	pvr	pvr	NOUN
aiua-10985	27	6	were	be	AUX
aiua-10985	27	7	evaluated	evaluate	VERB
aiua-10985	27	8	by	by	ADP
aiua-10985	27	9	using	use	VERB
aiua-10985	27	10	transabdominal	transabdominal	NOUN
aiua-10985	27	11	ultrasound	ultrasound	NOUN
aiua-10985	27	12	.	.	PUNCT
aiua-10985	28	1	all	all	DET
aiua-10985	28	2	data	datum	NOUN
aiua-10985	28	3	were	be	AUX
aiua-10985	28	4	collected	collect	VERB
aiua-10985	28	5	prior	prior	ADV
aiua-10985	28	6	to	to	ADP
aiua-10985	28	7	the	the	DET
aiua-10985	28	8	discontinuation	discontinuation	NOUN
aiua-10985	28	9	of	of	ADP
aiua-10985	28	10	dutasteride	dutasteride	NOUN
aiua-10985	28	11	.	.	PUNCT
aiua-10985	29	1	the	the	DET
aiua-10985	29	2	follow	follow	VERB
aiua-10985	29	3	up	up	ADP
aiua-10985	29	4	period	period	NOUN
aiua-10985	29	5	after	after	ADP
aiua-10985	29	6	the	the	DET
aiua-10985	29	7	discontinuation	discontinuation	NOUN
aiua-10985	29	8	of	of	ADP
aiua-10985	29	9	dutasteride	dutasteride	NOUN
aiua-10985	29	10	lasted	last	VERB
aiua-10985	29	11	24	24	NUM
aiua-10985	29	12	months	month	NOUN
aiua-10985	29	13	.	.	PUNCT
aiua-10985	30	1	alpha-1	alpha-1	NUM
aiua-10985	30	2	blocker	blocker	NOUN
aiua-10985	30	3	monotherapy	monotherapy	NOUN
aiua-10985	30	4	was	be	AUX
aiua-10985	30	5	continued	continue	VERB
aiua-10985	30	6	during	during	ADP
aiua-10985	30	7	this	this	DET
aiua-10985	30	8	period	period	NOUN
aiua-10985	30	9	.	.	PUNCT
aiua-10985	31	1	ipss	ipss	PROPN
aiua-10985	31	2	,	,	PUNCT
aiua-10985	31	3	oabss	oabss	NOUN
aiua-10985	31	4	,	,	PUNCT
aiua-10985	31	5	prostate	prostate	NOUN
aiua-10985	31	6	volume	volume	NOUN
aiua-10985	31	7	(	(	PUNCT
aiua-10985	31	8	pv	pv	NOUN
aiua-10985	31	9	)	)	PUNCT
aiua-10985	31	10	,	,	PUNCT
aiua-10985	31	11	and	and	CCONJ
aiua-10985	31	12	pvr	pvr	NOUN
aiua-10985	31	13	were	be	AUX
aiua-10985	31	14	evaluated	evaluate	VERB
aiua-10985	31	15	at	at	ADP
aiua-10985	31	16	1	1	NUM
aiua-10985	31	17	,	,	PUNCT
aiua-10985	31	18	3	3	NUM
aiua-10985	31	19	,	,	PUNCT
aiua-10985	31	20	6	6	NUM
aiua-10985	31	21	,	,	PUNCT
aiua-10985	31	22	12	12	NUM
aiua-10985	31	23	,	,	PUNCT
aiua-10985	31	24	18	18	NUM
aiua-10985	31	25	,	,	PUNCT
aiua-10985	31	26	and	and	CCONJ
aiua-10985	31	27	24	24	NUM
aiua-10985	31	28	months	month	NOUN
aiua-10985	31	29	after	after	ADP
aiua-10985	31	30	the	the	DET
aiua-10985	31	31	discontinuation	discontinuation	NOUN
aiua-10985	31	32	of	of	ADP
aiua-10985	31	33	dutasteride	dutasteride	PROPN
aiua-10985	31	34	.	.	PUNCT
aiua-10985	32	1	patients	patient	NOUN
aiua-10985	32	2	were	be	AUX
aiua-10985	32	3	allowed	allow	VERB
aiua-10985	32	4	to	to	PART
aiua-10985	32	5	restart	restart	VERB
aiua-10985	32	6	dutasteride	dutasteride	NOUN
aiua-10985	32	7	during	during	ADP
aiua-10985	32	8	the	the	DET
aiua-10985	32	9	follow	follow	NOUN
aiua-10985	32	10	-	-	PUNCT
aiua-10985	32	11	up	up	NOUN
aiua-10985	32	12	period	period	NOUN
aiua-10985	32	13	according	accord	VERB
aiua-10985	32	14	to	to	ADP
aiua-10985	32	15	their	their	PRON
aiua-10985	32	16	desires	desire	NOUN
aiua-10985	32	17	and	and	CCONJ
aiua-10985	32	18	the	the	DET
aiua-10985	32	19	judgement	judgement	NOUN
aiua-10985	32	20	of	of	ADP
aiua-10985	32	21	the	the	DET
aiua-10985	32	22	attending	attend	VERB
aiua-10985	32	23	physician	physician	NOUN
aiua-10985	32	24	.	.	PUNCT
aiua-10985	33	1	statistical	statistical	ADJ
aiua-10985	33	2	analysis	analysis	NOUN
aiua-10985	33	3	statistical	statistical	ADJ
aiua-10985	33	4	analyses	analysis	NOUN
aiua-10985	33	5	were	be	AUX
aiua-10985	33	6	carried	carry	VERB
aiua-10985	33	7	out	out	ADP
aiua-10985	33	8	to	to	PART
aiua-10985	33	9	identify	identify	VERB
aiua-10985	33	10	clinical	clinical	ADJ
aiua-10985	33	11	parameters	parameter	NOUN
aiua-10985	33	12	that	that	PRON
aiua-10985	33	13	differed	differ	VERB
aiua-10985	33	14	significantly	significantly	ADV
aiua-10985	33	15	between	between	ADP
aiua-10985	33	16	the	the	DET
aiua-10985	33	17	dr	dr	PROPN
aiua-10985	33	18	and	and	CCONJ
aiua-10985	33	19	dd	dd	VERB
aiua-10985	33	20	groups	group	NOUN
aiua-10985	33	21	.	.	PUNCT
aiua-10985	34	1	the	the	DET
aiua-10985	34	2	results	result	NOUN
aiua-10985	34	3	are	be	AUX
aiua-10985	34	4	shown	show	VERB
aiua-10985	34	5	as	as	ADP
aiua-10985	34	6	the	the	DET
aiua-10985	34	7	mean	mean	PROPN
aiua-10985	34	8	±	±	NOUN
aiua-10985	34	9	standard	standard	NOUN
aiua-10985	34	10	error	error	NOUN
aiua-10985	34	11	(	(	PUNCT
aiua-10985	34	12	se	se	ADJ
aiua-10985	34	13	)	)	PUNCT
aiua-10985	34	14	.	.	PUNCT
aiua-10985	35	1	the	the	DET
aiua-10985	35	2	mann	mann	PROPN
aiua-10985	35	3	-	-	PUNCT
aiua-10985	35	4	whitney	whitney	PROPN
aiua-10985	35	5	u	u	PROPN
aiua-10985	35	6	test	test	NOUN
aiua-10985	35	7	and	and	CCONJ
aiua-10985	35	8	chi	chi	ADJ
aiua-10985	35	9	-	-	PUNCT
aiua-10985	35	10	squared	square	VERB
aiua-10985	35	11	test	test	NOUN
aiua-10985	35	12	were	be	AUX
aiua-10985	35	13	used	use	VERB
aiua-10985	35	14	for	for	ADP
aiua-10985	35	15	the	the	DET
aiua-10985	35	16	statistical	statistical	ADJ
aiua-10985	35	17	analyses	analysis	NOUN
aiua-10985	35	18	.	.	PUNCT
aiua-10985	36	1	the	the	DET
aiua-10985	36	2	cox	cox	PROPN
aiua-10985	36	3	proportional	proportional	PROPN
aiua-10985	36	4	hazards	hazard	NOUN
aiua-10985	36	5	model	model	NOUN
aiua-10985	36	6	was	be	AUX
aiua-10985	36	7	used	use	VERB
aiua-10985	36	8	to	to	PART
aiua-10985	36	9	estimate	estimate	VERB
aiua-10985	36	10	the	the	DET
aiua-10985	36	11	relative	relative	ADJ
aiua-10985	36	12	risk	risk	NOUN
aiua-10985	36	13	of	of	ADP
aiua-10985	36	14	dutasteride	dutasteride	NOUN
aiua-10985	36	15	being	be	AUX
aiua-10985	36	16	restarted	restart	VERB
aiua-10985	36	17	associated	associate	VERB
aiua-10985	36	18	with	with	ADP
aiua-10985	36	19	each	each	DET
aiua-10985	36	20	parameter	parameter	NOUN
aiua-10985	36	21	.	.	PUNCT
aiua-10985	37	1	rate	rate	NOUN
aiua-10985	37	2	estimates	estimate	NOUN
aiua-10985	37	3	were	be	AUX
aiua-10985	37	4	calculated	calculate	VERB
aiua-10985	37	5	using	use	VERB
aiua-10985	37	6	the	the	DET
aiua-10985	37	7	kaplan	kaplan	PROPN
aiua-10985	37	8	-	-	PUNCT
aiua-10985	37	9	meier	meier	PROPN
aiua-10985	37	10	method	method	NOUN
aiua-10985	37	11	.	.	PUNCT
aiua-10985	38	1	the	the	DET
aiua-10985	38	2	logrank	logrank	PROPN
aiua-10985	38	3	test	test	NOUN
aiua-10985	38	4	was	be	AUX
aiua-10985	38	5	used	use	VERB
aiua-10985	38	6	to	to	PART
aiua-10985	38	7	evaluate	evaluate	VERB
aiua-10985	38	8	differences	difference	NOUN
aiua-10985	38	9	in	in	ADP
aiua-10985	38	10	rates	rate	NOUN
aiua-10985	38	11	between	between	ADP
aiua-10985	38	12	the	the	DET
aiua-10985	38	13	groups	group	NOUN
aiua-10985	38	14	.	.	PUNCT
aiua-10985	39	1	all	all	DET
aiua-10985	39	2	analyses	analysis	NOUN
aiua-10985	39	3	were	be	AUX
aiua-10985	39	4	performed	perform	VERB
aiua-10985	39	5	with	with	ADP
aiua-10985	39	6	jmp	jmp	PROPN
aiua-10985	39	7	version	version	PROPN
aiua-10985	39	8	10	10	NUM
aiua-10985	39	9	(	(	PUNCT
aiua-10985	39	10	sas	sas	PROPN
aiua-10985	39	11	institute	institute	PROPN
aiua-10985	39	12	inc	inc	PROPN
aiua-10985	39	13	.	.	PROPN
aiua-10985	39	14	,	,	PUNCT
aiua-10985	39	15	cary	cary	PROPN
aiua-10985	39	16	,	,	PUNCT
aiua-10985	39	17	nc	nc	PROPN
aiua-10985	39	18	,	,	PUNCT
aiua-10985	39	19	usa	usa	PROPN
aiua-10985	39	20	)	)	PUNCT
aiua-10985	39	21	.	.	PUNCT
aiua-10985	40	1	probability	probability	NOUN
aiua-10985	40	2	values	value	NOUN
aiua-10985	40	3	of	of	ADP
aiua-10985	40	4	<	<	X
aiua-10985	40	5	0.05	0.05	NUM
aiua-10985	40	6	were	be	AUX
aiua-10985	40	7	considered	consider	VERB
aiua-10985	40	8	statistically	statistically	ADV
aiua-10985	40	9	significant	significant	ADJ
aiua-10985	40	10	.	.	PUNCT
aiua-10985	41	1	ethical	ethical	ADJ
aiua-10985	41	2	approval	approval	NOUN
aiua-10985	41	3	the	the	DET
aiua-10985	41	4	institutional	institutional	ADJ
aiua-10985	41	5	review	review	NOUN
aiua-10985	41	6	board	board	NOUN
aiua-10985	41	7	of	of	ADP
aiua-10985	41	8	teikyo	teikyo	PROPN
aiua-10985	41	9	university	university	PROPN
aiua-10985	41	10	approved	approve	VERB
aiua-10985	41	11	this	this	DET
aiua-10985	41	12	study	study	NOUN
aiua-10985	41	13	(	(	PUNCT
aiua-10985	41	14	tuic	tuic	NOUN
aiua-10985	41	15	-	-	PUNCT
aiua-10985	41	16	coi	coi	NOUN
aiua-10985	41	17	21	21	NUM
aiua-10985	41	18	-	-	SYM
aiua-10985	41	19	179	179	NUM
aiua-10985	41	20	)	)	PUNCT
aiua-10985	41	21	.	.	PUNCT
aiua-10985	42	1	results	result	VERB
aiua-10985	42	2	out	out	ADP
aiua-10985	42	3	of	of	ADP
aiua-10985	42	4	39	39	NUM
aiua-10985	42	5	eligible	eligible	ADJ
aiua-10985	42	6	patients	patient	NOUN
aiua-10985	42	7	,	,	PUNCT
aiua-10985	42	8	36	36	NUM
aiua-10985	42	9	were	be	AUX
aiua-10985	42	10	analyzed	analyze	VERB
aiua-10985	42	11	at	at	ADP
aiua-10985	42	12	24	24	NUM
aiua-10985	42	13	months	month	NOUN
aiua-10985	42	14	,	,	PUNCT
aiua-10985	42	15	and	and	CCONJ
aiua-10985	42	16	13	13	NUM
aiua-10985	42	17	patients	patient	NOUN
aiua-10985	42	18	(	(	PUNCT
aiua-10985	42	19	13/36	13/36	NUM
aiua-10985	42	20	,	,	PUNCT
aiua-10985	42	21	36	36	NUM
aiua-10985	42	22	%	%	NOUN
aiua-10985	42	23	)	)	PUNCT
aiua-10985	42	24	restarted	restart	VERB
aiua-10985	42	25	dutasteride	dutasteride	NOUN
aiua-10985	42	26	.	.	PUNCT
aiua-10985	43	1	the	the	DET
aiua-10985	43	2	remaining	remain	VERB
aiua-10985	43	3	23	23	NUM
aiua-10985	43	4	patients	patient	NOUN
aiua-10985	43	5	(	(	PUNCT
aiua-10985	43	6	64	64	NUM
aiua-10985	43	7	%	%	NOUN
aiua-10985	43	8	)	)	PUNCT
aiua-10985	43	9	discontinued	discontinue	VERB
aiua-10985	43	10	dutasteride	dutasteride	NOUN
aiua-10985	43	11	within	within	ADP
aiua-10985	43	12	24	24	NUM
aiua-10985	43	13	months	month	NOUN
aiua-10985	43	14	as	as	SCONJ
aiua-10985	43	15	shown	show	VERB
aiua-10985	43	16	by	by	ADP
aiua-10985	43	17	the	the	DET
aiua-10985	43	18	kaplan	kaplan	PROPN
aiua-10985	43	19	-	-	PUNCT
aiua-10985	43	20	meier	meier	PROPN
aiua-10985	43	21	curve	curve	NOUN
aiua-10985	43	22	in	in	ADP
aiua-10985	43	23	figure	figure	NOUN
aiua-10985	43	24	1	1	NUM
aiua-10985	43	25	.	.	PUNCT
aiua-10985	44	1	neither	neither	CCONJ
aiua-10985	44	2	the	the	DET
aiua-10985	44	3	type	type	NOUN
aiua-10985	44	4	nor	nor	CCONJ
aiua-10985	44	5	dose	dose	VERB
aiua-10985	44	6	of	of	ADP
aiua-10985	44	7	alpha-1	alpha-1	PROPN
aiua-10985	44	8	blocker	blocker	NOUN
aiua-10985	44	9	was	be	AUX
aiua-10985	44	10	changed	change	VERB
aiua-10985	44	11	during	during	ADP
aiua-10985	44	12	the	the	DET
aiua-10985	44	13	follow	follow	NOUN
aiua-10985	44	14	-	-	PUNCT
aiua-10985	44	15	up	up	NOUN
aiua-10985	44	16	period	period	NOUN
aiua-10985	44	17	in	in	ADP
aiua-10985	44	18	any	any	DET
aiua-10985	44	19	patient	patient	NOUN
aiua-10985	44	20	.	.	PUNCT
aiua-10985	45	1	the	the	DET
aiua-10985	45	2	mean	mean	ADJ
aiua-10985	45	3	number	number	NOUN
aiua-10985	45	4	of	of	ADP
aiua-10985	45	5	different	different	ADJ
aiua-10985	45	6	types	type	NOUN
aiua-10985	45	7	of	of	ADP
aiua-10985	45	8	medications	medication	NOUN
aiua-10985	45	9	being	be	AUX
aiua-10985	45	10	taken	take	VERB
aiua-10985	45	11	by	by	ADP
aiua-10985	45	12	the	the	DET
aiua-10985	45	13	patients	patient	NOUN
aiua-10985	45	14	in	in	ADP
aiua-10985	45	15	the	the	DET
aiua-10985	45	16	dr	dr	PROPN
aiua-10985	45	17	and	and	CCONJ
aiua-10985	45	18	dd	dd	VERB
aiua-10985	45	19	groups	group	NOUN
aiua-10985	45	20	was	be	AUX
aiua-10985	45	21	6.5	6.5	NUM
aiua-10985	45	22	and	and	CCONJ
aiua-10985	45	23	5.7	5.7	NUM
aiua-10985	45	24	,	,	PUNCT
aiua-10985	45	25	respectively	respectively	ADV
aiua-10985	45	26	.	.	PUNCT
aiua-10985	46	1	the	the	DET
aiua-10985	46	2	mean	mean	ADJ
aiua-10985	46	3	number	number	NOUN
aiua-10985	46	4	of	of	ADP
aiua-10985	46	5	nocturia	nocturia	ADJ
aiua-10985	46	6	events	event	NOUN
aiua-10985	46	7	experienced	experience	VERB
aiua-10985	46	8	per	per	ADP
aiua-10985	46	9	day	day	NOUN
aiua-10985	46	10	before	before	ADP
aiua-10985	46	11	the	the	DET
aiua-10985	46	12	discontinuation	discontinuation	NOUN
aiua-10985	46	13	of	of	ADP
aiua-10985	46	14	dutasteride	dutasteride	NOUN
aiua-10985	46	15	was	be	AUX
aiua-10985	46	16	significantly	significantly	ADV
aiua-10985	46	17	higher	high	ADJ
aiua-10985	46	18	in	in	ADP
aiua-10985	46	19	the	the	DET
aiua-10985	46	20	dr	dr	PROPN
aiua-10985	46	21	group	group	NOUN
aiua-10985	46	22	than	than	ADP
aiua-10985	46	23	in	in	ADP
aiua-10985	46	24	the	the	DET
aiua-10985	46	25	dd	dd	NOUN
aiua-10985	46	26	group	group	NOUN
aiua-10985	46	27	(	(	PUNCT
aiua-10985	46	28	2.8	2.8	NUM
aiua-10985	46	29	vs	vs	ADP
aiua-10985	46	30	1.8	1.8	NUM
aiua-10985	46	31	,	,	PUNCT
aiua-10985	46	32	respectively	respectively	ADV
aiua-10985	46	33	;	;	PUNCT
aiua-10985	46	34	p	p	X
aiua-10985	46	35	=	=	NOUN
aiua-10985	46	36	0.005	0.005	NUM
aiua-10985	46	37	)	)	PUNCT
aiua-10985	46	38	.	.	PUNCT
aiua-10985	47	1	the	the	DET
aiua-10985	47	2	mean	mean	ADJ
aiua-10985	47	3	duration	duration	NOUN
aiua-10985	47	4	of	of	ADP
aiua-10985	47	5	dutasteride	dutasteride	PROPN
aiua-10985	47	6	treatment	treatment	NOUN
aiua-10985	47	7	prior	prior	ADV
aiua-10985	47	8	to	to	ADP
aiua-10985	47	9	discontinuation	discontinuation	NOUN
aiua-10985	47	10	was	be	AUX
aiua-10985	47	11	significantly	significantly	ADV
aiua-10985	47	12	longer	long	ADJ
aiua-10985	47	13	in	in	ADP
aiua-10985	47	14	the	the	DET
aiua-10985	47	15	dr	dr	PROPN
aiua-10985	47	16	group	group	NOUN
aiua-10985	47	17	(	(	PUNCT
aiua-10985	47	18	37	37	NUM
aiua-10985	47	19	months	month	NOUN
aiua-10985	47	20	)	)	PUNCT
aiua-10985	47	21	than	than	ADP
aiua-10985	47	22	in	in	ADP
aiua-10985	47	23	the	the	DET
aiua-10985	47	24	dd	dd	NOUN
aiua-10985	47	25	group	group	NOUN
aiua-10985	47	26	(	(	PUNCT
aiua-10985	47	27	25	25	NUM
aiua-10985	47	28	months	month	NOUN
aiua-10985	47	29	)	)	PUNCT
aiua-10985	47	30	(	(	PUNCT
aiua-10985	47	31	p	p	X
aiua-10985	47	32	=	=	NOUN
aiua-10985	47	33	0.0261	0.0261	NUM
aiua-10985	47	34	)	)	PUNCT
aiua-10985	47	35	(	(	PUNCT
aiua-10985	47	36	table	table	NOUN
aiua-10985	47	37	1	1	NUM
aiua-10985	47	38	)	)	PUNCT
aiua-10985	47	39	.	.	PUNCT
aiua-10985	48	1	the	the	DET
aiua-10985	48	2	pvr	pvr	NOUN
aiua-10985	48	3	before	before	ADP
aiua-10985	48	4	the	the	DET
aiua-10985	48	5	discontinuation	discontinuation	NOUN
aiua-10985	48	6	of	of	ADP
aiua-10985	48	7	dutasteride	dutasteride	NOUN
aiua-10985	48	8	was	be	AUX
aiua-10985	48	9	not	not	PART
aiua-10985	48	10	significantly	significantly	ADV
aiua-10985	48	11	different	different	ADJ
aiua-10985	48	12	in	in	ADP
aiua-10985	48	13	the	the	DET
aiua-10985	48	14	dr	dr	PROPN
aiua-10985	48	15	group	group	PROPN
aiua-10985	48	16	(	(	PUNCT
aiua-10985	48	17	59	59	NUM
aiua-10985	48	18	ml	ml	NOUN
aiua-10985	48	19	)	)	PUNCT
aiua-10985	48	20	compared	compare	VERB
aiua-10985	48	21	to	to	ADP
aiua-10985	48	22	the	the	DET
aiua-10985	48	23	dd	dd	NOUN
aiua-10985	48	24	group	group	NOUN
aiua-10985	48	25	(	(	PUNCT
aiua-10985	48	26	35	35	NUM
aiua-10985	48	27	ml	ml	NOUN
aiua-10985	48	28	)	)	PUNCT
aiua-10985	48	29	(	(	PUNCT
aiua-10985	48	30	p	p	X
aiua-10985	48	31	=	=	NOUN
aiua-10985	48	32	0.0868	0.0868	NUM
aiua-10985	48	33	)	)	PUNCT
aiua-10985	48	34	.	.	PUNCT
aiua-10985	49	1	total	total	ADJ
aiua-10985	49	2	ipss	ipss	PROPN
aiua-10985	49	3	and	and	CCONJ
aiua-10985	49	4	total	total	ADJ
aiua-10985	49	5	oabss	oabss	NOUN
aiua-10985	49	6	were	be	AUX
aiua-10985	49	7	also	also	ADV
aiua-10985	49	8	not	not	PART
aiua-10985	49	9	significantly	significantly	ADV
aiua-10985	49	10	higher	high	ADJ
aiua-10985	49	11	in	in	ADP
aiua-10985	49	12	the	the	DET
aiua-10985	49	13	dr	dr	PROPN
aiua-10985	49	14	group	group	NOUN
aiua-10985	49	15	than	than	ADP
aiua-10985	49	16	in	in	ADP
aiua-10985	49	17	the	the	DET
aiua-10985	49	18	dd	dd	PROPN
aiua-10985	49	19	group	group	NOUN
aiua-10985	49	20	.	.	PUNCT
aiua-10985	50	1	multivariate	multivariate	NOUN
aiua-10985	50	2	analysis	analysis	NOUN
aiua-10985	50	3	showed	show	VERB
aiua-10985	50	4	statistically	statistically	ADV
aiua-10985	50	5	significant	significant	ADJ
aiua-10985	50	6	differences	difference	NOUN
aiua-10985	50	7	in	in	ADP
aiua-10985	50	8	the	the	DET
aiua-10985	50	9	duration	duration	NOUN
aiua-10985	50	10	of	of	ADP
aiua-10985	50	11	dutasteride	dutasteride	NOUN
aiua-10985	50	12	treatment	treatment	NOUN
aiua-10985	50	13	before	before	ADP
aiua-10985	50	14	discontinuation	discontinuation	NOUN
aiua-10985	50	15	and	and	CCONJ
aiua-10985	50	16	the	the	DET
aiua-10985	50	17	frequency	frequency	NOUN
aiua-10985	50	18	of	of	ADP
aiua-10985	50	19	nocturia	nocturia	PROPN
aiua-10985	50	20	between	between	ADP
aiua-10985	50	21	the	the	DET
aiua-10985	50	22	groups	group	NOUN
aiua-10985	50	23	.	.	PUNCT
aiua-10985	51	1	in	in	ADP
aiua-10985	51	2	dd	dd	PROPN
aiua-10985	51	3	group	group	NOUN
aiua-10985	51	4	,	,	PUNCT
aiua-10985	51	5	the	the	DET
aiua-10985	51	6	change	change	NOUN
aiua-10985	51	7	from	from	ADP
aiua-10985	51	8	baseline	baseline	NOUN
aiua-10985	51	9	of	of	ADP
aiua-10985	51	10	mean	mean	PROPN
aiua-10985	51	11	ipss	ipss	PROPN
aiua-10985	51	12	values	value	NOUN
aiua-10985	51	13	(	(	PUNCT
aiua-10985	51	14	δ	δ	PROPN
aiua-10985	51	15	-	-	PUNCT
aiua-10985	51	16	ipss	ipss	PROPN
aiua-10985	51	17	)	)	PUNCT
aiua-10985	51	18	at	at	ADP
aiua-10985	51	19	1	1	NUM
aiua-10985	51	20	,	,	PUNCT
aiua-10985	51	21	3	3	NUM
aiua-10985	51	22	,	,	PUNCT
aiua-10985	51	23	6	6	NUM
aiua-10985	51	24	,	,	PUNCT
aiua-10985	51	25	12	12	NUM
aiua-10985	51	26	,	,	PUNCT
aiua-10985	51	27	18	18	NUM
aiua-10985	51	28	,	,	PUNCT
aiua-10985	51	29	and	and	CCONJ
aiua-10985	51	30	24	24	NUM
aiua-10985	51	31	months	month	NOUN
aiua-10985	51	32	were	be	AUX
aiua-10985	51	33	±0	±0	ADJ
aiua-10985	51	34	,	,	PUNCT
aiua-10985	51	35	+0.6	+0.6	NUM
aiua-10985	51	36	,	,	PUNCT
aiua-10985	51	37	+0.3	+0.3	PROPN
aiua-10985	51	38	,	,	PUNCT
aiua-10985	51	39	+0.6	+0.6	NUM
aiua-10985	51	40	,	,	PUNCT
aiua-10985	51	41	+0.9	+0.9	NOUN
aiua-10985	51	42	,	,	PUNCT
aiua-10985	51	43	and	and	CCONJ
aiua-10985	51	44	+0.6	+0.6	NUM
aiua-10985	51	45	,	,	PUNCT
aiua-10985	51	46	respectively	respectively	ADV
aiua-10985	51	47	(	(	PUNCT
aiua-10985	51	48	p	p	X
aiua-10985	51	49	=	=	NOUN
aiua-10985	51	50	0.9985	0.9985	NUM
aiua-10985	51	51	)	)	PUNCT
aiua-10985	51	52	,	,	PUNCT
aiua-10985	51	53	the	the	DET
aiua-10985	51	54	δ	δ	NOUN
aiua-10985	51	55	-	-	PUNCT
aiua-10985	51	56	oabss	oabss	NOUN
aiua-10985	51	57	values	value	NOUN
aiua-10985	51	58	at	at	ADP
aiua-10985	51	59	1	1	NUM
aiua-10985	51	60	,	,	PUNCT
aiua-10985	51	61	3	3	NUM
aiua-10985	51	62	,	,	PUNCT
aiua-10985	51	63	6	6	NUM
aiua-10985	51	64	,	,	PUNCT
aiua-10985	51	65	12,18	12,18	NUM
aiua-10985	51	66	,	,	PUNCT
aiua-10985	51	67	and	and	CCONJ
aiua-10985	51	68	24	24	NUM
aiua-10985	51	69	table	table	NOUN
aiua-10985	51	70	1	1	NUM
aiua-10985	51	71	.	.	PUNCT
aiua-10985	52	1	patient	patient	ADJ
aiua-10985	52	2	characteristics	characteristic	NOUN
aiua-10985	52	3	.	.	PUNCT
aiua-10985	53	1	variables	variables	PROPN
aiua-10985	53	2	dr	dr	PROPN
aiua-10985	53	3	group	group	PROPN
aiua-10985	53	4	dd	dd	PROPN
aiua-10985	53	5	group	group	NOUN
aiua-10985	53	6	p	p	NOUN
aiua-10985	53	7	-	-	PUNCT
aiua-10985	53	8	value	value	NOUN
aiua-10985	53	9	(	(	PUNCT
aiua-10985	53	10	n=13	n=13	NOUN
aiua-10985	53	11	)	)	PUNCT
aiua-10985	53	12	(	(	PUNCT
aiua-10985	53	13	n=23	n=23	PROPN
aiua-10985	53	14	)	)	PUNCT
aiua-10985	53	15	age	age	NOUN
aiua-10985	53	16	(	(	PUNCT
aiua-10985	53	17	mean	mean	PROPN
aiua-10985	53	18	±	±	NUM
aiua-10985	53	19	se	se	X
aiua-10985	53	20	)	)	PUNCT
aiua-10985	53	21	,	,	PUNCT
aiua-10985	53	22	years	year	NOUN
aiua-10985	53	23	79	79	NUM
aiua-10985	53	24	±	±	NUM
aiua-10985	53	25	2.2	2.2	NUM
aiua-10985	53	26	76	76	NUM
aiua-10985	53	27	±	±	NUM
aiua-10985	53	28	1.3	1.3	NUM
aiua-10985	53	29	0.2283	0.2283	NUM
aiua-10985	53	30	bmi	bmi	NOUN
aiua-10985	53	31	(	(	PUNCT
aiua-10985	53	32	mean	mean	NOUN
aiua-10985	53	33	±	±	NUM
aiua-10985	53	34	se	se	X
aiua-10985	53	35	)	)	PUNCT
aiua-10985	53	36	,	,	PUNCT
aiua-10985	53	37	kg	kg	PROPN
aiua-10985	53	38	/	/	SYM
aiua-10985	53	39	m2	m2	PROPN
aiua-10985	53	40	23.3	23.3	NUM
aiua-10985	53	41	±	±	NUM
aiua-10985	53	42	0.9	0.9	NUM
aiua-10985	53	43	23.3	23.3	NUM
aiua-10985	53	44	±	±	NUM
aiua-10985	53	45	0.6	0.6	NUM
aiua-10985	53	46	0.6523	0.6523	NUM
aiua-10985	53	47	prostate	prostate	NOUN
aiua-10985	53	48	volume	volume	NOUN
aiua-10985	53	49	(	(	PUNCT
aiua-10985	53	50	mean	mean	PROPN
aiua-10985	53	51	±	±	NUM
aiua-10985	53	52	se	se	X
aiua-10985	53	53	)	)	PUNCT
aiua-10985	53	54	,	,	PUNCT
aiua-10985	53	55	ml	ml	ADP
aiua-10985	53	56	46.3	46.3	NUM
aiua-10985	53	57	±	±	NUM
aiua-10985	53	58	7.3	7.3	NUM
aiua-10985	53	59	45	45	NUM
aiua-10985	53	60	±	±	NUM
aiua-10985	53	61	3.6	3.6	NUM
aiua-10985	53	62	0.781	0.781	NUM
aiua-10985	53	63	hypertension	hypertension	NOUN
aiua-10985	53	64	,	,	PUNCT
aiua-10985	53	65	n	n	CCONJ
aiua-10985	53	66	(	(	PUNCT
aiua-10985	53	67	%	%	INTJ
aiua-10985	53	68	)	)	PUNCT
aiua-10985	53	69	9	9	NUM
aiua-10985	53	70	(	(	PUNCT
aiua-10985	53	71	75	75	NUM
aiua-10985	53	72	%	%	NOUN
aiua-10985	53	73	)	)	PUNCT
aiua-10985	53	74	12	12	NUM
aiua-10985	53	75	(	(	PUNCT
aiua-10985	53	76	52	52	NUM
aiua-10985	53	77	%	%	NOUN
aiua-10985	53	78	)	)	PUNCT
aiua-10985	53	79	0.1907	0.1907	NUM
aiua-10985	53	80	diabetes	diabetes	NOUN
aiua-10985	53	81	mellitus	mellitus	NOUN
aiua-10985	53	82	,	,	PUNCT
aiua-10985	53	83	n	n	PROPN
aiua-10985	53	84	(	(	PUNCT
aiua-10985	53	85	%	%	INTJ
aiua-10985	53	86	)	)	PUNCT
aiua-10985	53	87	2	2	NUM
aiua-10985	53	88	(	(	PUNCT
aiua-10985	53	89	17	17	NUM
aiua-10985	53	90	%	%	NOUN
aiua-10985	53	91	)	)	PUNCT
aiua-10985	53	92	2	2	NUM
aiua-10985	53	93	(	(	PUNCT
aiua-10985	53	94	9	9	NUM
aiua-10985	53	95	%	%	NOUN
aiua-10985	53	96	)	)	PUNCT
aiua-10985	53	97	0.4817	0.4817	NUM
aiua-10985	53	98	dyslipidemia	dyslipidemia	NOUN
aiua-10985	53	99	,	,	PUNCT
aiua-10985	53	100	n	n	PROPN
aiua-10985	53	101	(	(	PUNCT
aiua-10985	53	102	%	%	INTJ
aiua-10985	53	103	)	)	PUNCT
aiua-10985	53	104	0	0	NUM
aiua-10985	54	1	(	(	PUNCT
aiua-10985	54	2	0	0	NUM
aiua-10985	54	3	%	%	NOUN
aiua-10985	54	4	)	)	PUNCT
aiua-10985	54	5	6	6	NUM
aiua-10985	54	6	(	(	PUNCT
aiua-10985	54	7	26	26	NUM
aiua-10985	54	8	%	%	NOUN
aiua-10985	54	9	)	)	PUNCT
aiua-10985	55	1	0.0519	0.0519	NUM
aiua-10985	55	2	no	no	INTJ
aiua-10985	55	3	.	.	PUNCT
aiua-10985	55	4	of	of	ADP
aiua-10985	55	5	types	type	NOUN
aiua-10985	55	6	of	of	ADP
aiua-10985	55	7	medications	medication	NOUN
aiua-10985	55	8	being	be	AUX
aiua-10985	55	9	taken	take	VERB
aiua-10985	55	10	(	(	PUNCT
aiua-10985	55	11	mean	mean	PROPN
aiua-10985	55	12	±	±	NUM
aiua-10985	55	13	se	se	X
aiua-10985	55	14	)	)	PUNCT
aiua-10985	55	15	6.5	6.5	NUM
aiua-10985	55	16	±	±	NUM
aiua-10985	55	17	2.2	2.2	NUM
aiua-10985	55	18	5.7	5.7	NUM
aiua-10985	55	19	±	±	NUM
aiua-10985	55	20	2.2	2.2	NUM
aiua-10985	55	21	0.3334	0.3334	NUM
aiua-10985	55	22	duration	duration	NOUN
aiua-10985	55	23	of	of	ADP
aiua-10985	55	24	dutasteride	dutasteride	PROPN
aiua-10985	55	25	treatment	treatment	NOUN
aiua-10985	55	26	(	(	PUNCT
aiua-10985	55	27	mean	mean	PROPN
aiua-10985	55	28	±	±	NUM
aiua-10985	55	29	se	se	X
aiua-10985	55	30	)	)	PUNCT
aiua-10985	55	31	,	,	PUNCT
aiua-10985	55	32	months	month	NOUN
aiua-10985	55	33	37	37	NUM
aiua-10985	55	34	±	±	NUM
aiua-10985	55	35	4.6	4.6	NUM
aiua-10985	55	36	24	24	NUM
aiua-10985	55	37	±	±	NUM
aiua-10985	55	38	3.5	3.5	NUM
aiua-10985	55	39	0.0261	0.0261	NUM
aiua-10985	55	40	no	no	NOUN
aiua-10985	55	41	.	.	PUNCT
aiua-10985	55	42	of	of	ADP
aiua-10985	55	43	nocturia	nocturia	PROPN
aiua-10985	55	44	events	event	NOUN
aiua-10985	55	45	per	per	ADP
aiua-10985	55	46	night	night	NOUN
aiua-10985	55	47	(	(	PUNCT
aiua-10985	55	48	mean	mean	NOUN
aiua-10985	55	49	±	±	NUM
aiua-10985	55	50	se	se	X
aiua-10985	55	51	)	)	PUNCT
aiua-10985	55	52	2.8	2.8	NUM
aiua-10985	55	53	±	±	NUM
aiua-10985	55	54	0.3	0.3	NUM
aiua-10985	55	55	1.7	1.7	NUM
aiua-10985	55	56	±	±	NUM
aiua-10985	55	57	0.2	0.2	NUM
aiua-10985	55	58	0.0050	0.0050	NUM
aiua-10985	55	59	total	total	ADJ
aiua-10985	55	60	ipss	ipss	PROPN
aiua-10985	55	61	(	(	PUNCT
aiua-10985	55	62	mean	mean	PROPN
aiua-10985	55	63	±	±	NUM
aiua-10985	55	64	se	se	X
aiua-10985	55	65	)	)	PUNCT
aiua-10985	55	66	14.3	14.3	NUM
aiua-10985	55	67	±	±	NUM
aiua-10985	55	68	1.7	1.7	NUM
aiua-10985	55	69	11.7	11.7	NUM
aiua-10985	55	70	±	±	NUM
aiua-10985	55	71	1.3	1.3	NUM
aiua-10985	55	72	0.1294	0.1294	NUM
aiua-10985	55	73	urinary	urinary	ADJ
aiua-10985	55	74	symptom	symptom	NOUN
aiua-10985	55	75	score	score	NOUN
aiua-10985	55	76	(	(	PUNCT
aiua-10985	55	77	mean	mean	NOUN
aiua-10985	55	78	±	±	NUM
aiua-10985	55	79	se	se	X
aiua-10985	55	80	)	)	PUNCT
aiua-10985	55	81	6.0	6.0	NUM
aiua-10985	55	82	±	±	NUM
aiua-10985	55	83	1.0	1.0	NUM
aiua-10985	55	84	5.5	5.5	NUM
aiua-10985	55	85	±	±	NUM
aiua-10985	55	86	0.7	0.7	NUM
aiua-10985	55	87	0.7005	0.7005	NUM
aiua-10985	55	88	irritative	irritative	ADJ
aiua-10985	55	89	symptom	symptom	NOUN
aiua-10985	55	90	score	score	NOUN
aiua-10985	55	91	(	(	PUNCT
aiua-10985	55	92	mean	mean	PROPN
aiua-10985	55	93	±	±	NUM
aiua-10985	55	94	se	se	X
aiua-10985	55	95	)	)	PUNCT
aiua-10985	55	96	5.5	5.5	NUM
aiua-10985	55	97	±	±	NUM
aiua-10985	55	98	1.2	1.2	NUM
aiua-10985	55	99	4.4	4.4	NUM
aiua-10985	55	100	±	±	NUM
aiua-10985	55	101	0.6	0.6	NUM
aiua-10985	55	102	0.31	0.31	NUM
aiua-10985	55	103	qol	qol	NOUN
aiua-10985	55	104	score	score	NOUN
aiua-10985	55	105	(	(	PUNCT
aiua-10985	55	106	mean	mean	PROPN
aiua-10985	55	107	±	±	NUM
aiua-10985	55	108	se	se	X
aiua-10985	55	109	)	)	PUNCT
aiua-10985	55	110	2.8	2.8	NUM
aiua-10985	55	111	±	±	NUM
aiua-10985	55	112	0.6	0.6	NUM
aiua-10985	55	113	3.2	3.2	NUM
aiua-10985	55	114	±	±	NUM
aiua-10985	55	115	0.3	0.3	NUM
aiua-10985	55	116	0.6329	0.6329	NUM
aiua-10985	55	117	total	total	ADJ
aiua-10985	55	118	oabss	oabss	NOUN
aiua-10985	55	119	(	(	PUNCT
aiua-10985	55	120	mean	mean	NOUN
aiua-10985	55	121	±	±	NUM
aiua-10985	55	122	se	se	X
aiua-10985	55	123	)	)	PUNCT
aiua-10985	55	124	5.3	5.3	NUM
aiua-10985	55	125	±	±	NUM
aiua-10985	55	126	1.5	1.5	NUM
aiua-10985	55	127	4.2	4.2	NUM
aiua-10985	55	128	±	±	NUM
aiua-10985	55	129	0.6	0.6	NUM
aiua-10985	55	130	0.7391	0.7391	NUM
aiua-10985	55	131	pvr	pvr	NOUN
aiua-10985	55	132	(	(	PUNCT
aiua-10985	55	133	mean	mean	PROPN
aiua-10985	55	134	±	±	NUM
aiua-10985	55	135	se	se	X
aiua-10985	55	136	)	)	PUNCT
aiua-10985	55	137	,	,	PUNCT
aiua-10985	55	138	ml	ml	PROPN
aiua-10985	55	139	59	59	NUM
aiua-10985	55	140	±	±	NUM
aiua-10985	55	141	16	16	NUM
aiua-10985	55	142	35	35	NUM
aiua-10985	55	143	±	±	NUM
aiua-10985	55	144	7.3	7.3	NUM
aiua-10985	55	145	0.0868	0.0868	NUM
aiua-10985	55	146	reduction	reduction	NOUN
aiua-10985	55	147	rate	rate	NOUN
aiua-10985	55	148	(	(	PUNCT
aiua-10985	55	149	mean	mean	PROPN
aiua-10985	55	150	±	±	NUM
aiua-10985	55	151	se	se	X
aiua-10985	55	152	)	)	PUNCT
aiua-10985	55	153	,	,	PUNCT
aiua-10985	55	154	%	%	NOUN
aiua-10985	55	155	12.4	12.4	NUM
aiua-10985	55	156	±	±	NUM
aiua-10985	55	157	4.3	4.3	NUM
aiua-10985	55	158	14.4	14.4	NUM
aiua-10985	55	159	±	±	NUM
aiua-10985	55	160	4.1	4.1	NUM
aiua-10985	55	161	0.8894	0.8894	NUM
aiua-10985	55	162	overactive	overactive	ADJ
aiua-10985	55	163	bladder	bladder	NOUN
aiua-10985	55	164	symptom	symptom	NOUN
aiua-10985	55	165	score	score	NOUN
aiua-10985	55	166	;	;	PUNCT
aiua-10985	55	167	pvr	pvr	NOUN
aiua-10985	55	168	:	:	PUNCT
aiua-10985	55	169	post	post	ADJ
aiua-10985	55	170	-	-	ADJ
aiua-10985	55	171	void	void	ADJ
aiua-10985	55	172	residual	residual	ADJ
aiua-10985	55	173	volume	volume	NOUN
aiua-10985	55	174	;	;	PUNCT
aiua-10985	55	175	se	se	X
aiua-10985	55	176	:	:	PUNCT
aiua-10985	55	177	standard	standard	ADJ
aiua-10985	55	178	error	error	NOUN
aiua-10985	55	179	.	.	PUNCT
aiua-10985	56	1	figure	figure	NOUN
aiua-10985	56	2	1	1	NUM
aiua-10985	56	3	.	.	PUNCT
aiua-10985	56	4	dutasteride	dutasteride	NOUN
aiua-10985	56	5	discontinuation	discontinuation	NOUN
aiua-10985	56	6	rate	rate	NOUN
aiua-10985	56	7	during	during	ADP
aiua-10985	56	8	the	the	DET
aiua-10985	56	9	2	2	NUM
aiua-10985	56	10	-	-	PUNCT
aiua-10985	56	11	year	year	NOUN
aiua-10985	56	12	follow	follow	NOUN
aiua-10985	56	13	-	-	PUNCT
aiua-10985	56	14	up	up	NOUN
aiua-10985	56	15	period	period	NOUN
aiua-10985	56	16	as	as	SCONJ
aiua-10985	56	17	determined	determine	VERB
aiua-10985	56	18	using	use	VERB
aiua-10985	56	19	a	a	DET
aiua-10985	56	20	kaplan	kaplan	PROPN
aiua-10985	56	21	-	-	PUNCT
aiua-10985	56	22	meier	meier	PROPN
aiua-10985	56	23	curve	curve	NOUN
aiua-10985	56	24	.	.	PUNCT
aiua-10985	57	1	the	the	DET
aiua-10985	57	2	discontinuation	discontinuation	NOUN
aiua-10985	57	3	rates	rate	NOUN
aiua-10985	57	4	at	at	ADP
aiua-10985	57	5	6	6	NUM
aiua-10985	57	6	,	,	PUNCT
aiua-10985	57	7	12	12	NUM
aiua-10985	57	8	,	,	PUNCT
aiua-10985	57	9	18	18	NUM
aiua-10985	57	10	,	,	PUNCT
aiua-10985	57	11	and	and	CCONJ
aiua-10985	57	12	24	24	NUM
aiua-10985	57	13	months	month	NOUN
aiua-10985	57	14	were	be	AUX
aiua-10985	57	15	87	87	NUM
aiua-10985	57	16	%	%	NOUN
aiua-10985	57	17	,	,	PUNCT
aiua-10985	57	18	74	74	NUM
aiua-10985	57	19	%	%	NOUN
aiua-10985	57	20	,	,	PUNCT
aiua-10985	57	21	64	64	NUM
aiua-10985	57	22	%	%	NOUN
aiua-10985	57	23	,	,	PUNCT
aiua-10985	57	24	and	and	CCONJ
aiua-10985	57	25	64	64	NUM
aiua-10985	57	26	%	%	NOUN
aiua-10985	57	27	,	,	PUNCT
aiua-10985	57	28	respectively	respectively	ADV
aiua-10985	57	29	.	.	PUNCT
aiua-10985	58	1	p	p	X
aiua-10985	59	1	ro	ro	X
aiua-10985	59	2	ba	ba	PROPN
aiua-10985	59	3	bi	bi	PROPN
aiua-10985	59	4	lit	light	VERB
aiua-10985	59	5	y	y	PROPN
aiua-10985	59	6	of	of	ADP
aiua-10985	59	7	d	d	PROPN
aiua-10985	59	8	is	be	AUX
aiua-10985	59	9	co	co	INTJ
aiua-10985	59	10	nt	not	PART
aiua-10985	59	11	in	in	ADP
aiua-10985	59	12	ua	ua	PROPN
aiua-10985	59	13	tio	tio	PROPN
aiua-10985	59	14	n	n	PROPN
aiua-10985	59	15	(	(	PUNCT
aiua-10985	59	16	%	%	NOUN
aiua-10985	59	17	)	)	PUNCT
aiua-10985	59	18	time	time	NOUN
aiua-10985	59	19	since	since	SCONJ
aiua-10985	59	20	discontinuation	discontinuation	NOUN
aiua-10985	59	21	(	(	PUNCT
aiua-10985	59	22	months	month	NOUN
aiua-10985	59	23	)	)	PUNCT
aiua-10985	59	24	523archivio	523archivio	PROPN
aiua-10985	59	25	italiano	italiano	NOUN
aiua-10985	59	26	di	di	NOUN
aiua-10985	59	27	urologia	urologia	PROPN
aiua-10985	59	28	e	e	PROPN
aiua-10985	59	29	andrologia	andrologia	PROPN
aiua-10985	59	30	2022	2022	NUM
aiua-10985	59	31	;	;	PUNCT
aiua-10985	59	32	94	94	NUM
aiua-10985	59	33	,	,	PUNCT
aiua-10985	59	34	4	4	NUM
aiua-10985	59	35	dutasteride	dutasteride	NOUN
aiua-10985	59	36	discontinuation	discontinuation	NOUN
aiua-10985	59	37	in	in	ADP
aiua-10985	59	38	bph	bph	NOUN
aiua-10985	59	39	months	month	NOUN
aiua-10985	59	40	were	be	AUX
aiua-10985	59	41	+0.1	+0.1	ADJ
aiua-10985	59	42	,	,	PUNCT
aiua-10985	59	43	+0.5	+0.5	NUM
aiua-10985	59	44	,	,	PUNCT
aiua-10985	59	45	+0.4	+0.4	NUM
aiua-10985	59	46	,	,	PUNCT
aiua-10985	59	47	+0.1	+0.1	NOUN
aiua-10985	59	48	,	,	PUNCT
aiua-10985	59	49	±0	±0	NOUN
aiua-10985	59	50	,	,	PUNCT
aiua-10985	59	51	and	and	CCONJ
aiua-10985	59	52	+0.6	+0.6	NUM
aiua-10985	59	53	,	,	PUNCT
aiua-10985	59	54	respectively	respectively	ADV
aiua-10985	59	55	(	(	PUNCT
aiua-10985	59	56	p	p	X
aiua-10985	59	57	=	=	NOUN
aiua-10985	59	58	0.9927	0.9927	NUM
aiua-10985	59	59	)	)	PUNCT
aiua-10985	59	60	,	,	PUNCT
aiua-10985	59	61	and	and	CCONJ
aiua-10985	59	62	the	the	DET
aiua-10985	59	63	mean	mean	ADJ
aiua-10985	59	64	δ	δ	PROPN
aiua-10985	59	65	-	-	PUNCT
aiua-10985	59	66	pvr	pvr	NOUN
aiua-10985	59	67	values	value	NOUN
aiua-10985	59	68	at	at	ADP
aiua-10985	59	69	1	1	NUM
aiua-10985	59	70	,	,	PUNCT
aiua-10985	59	71	3	3	NUM
aiua-10985	59	72	,	,	PUNCT
aiua-10985	59	73	6	6	NUM
aiua-10985	59	74	,	,	PUNCT
aiua-10985	59	75	12,18	12,18	NUM
aiua-10985	59	76	,	,	PUNCT
aiua-10985	59	77	and	and	CCONJ
aiua-10985	59	78	24	24	NUM
aiua-10985	59	79	months	month	NOUN
aiua-10985	59	80	were	be	AUX
aiua-10985	59	81	-6.4	-6.4	ADJ
aiua-10985	59	82	,	,	PUNCT
aiua-10985	59	83	-3.0	-3.0	PUNCT
aiua-10985	59	84	,	,	PUNCT
aiua-10985	59	85	-6.3	-6.3	NOUN
aiua-10985	59	86	,	,	PUNCT
aiua-10985	59	87	-1.4	-1.4	NOUN
aiua-10985	59	88	,	,	PUNCT
aiua-10985	59	89	+0.3	+0.3	PROPN
aiua-10985	59	90	,	,	PUNCT
aiua-10985	59	91	and	and	CCONJ
aiua-10985	59	92	-3.3	-3.3	NOUN
aiua-10985	59	93	,	,	PUNCT
aiua-10985	59	94	respectively	respectively	ADV
aiua-10985	59	95	(	(	PUNCT
aiua-10985	59	96	p	p	X
aiua-10985	59	97	=	=	NOUN
aiua-10985	59	98	0.9920	0.9920	NUM
aiua-10985	59	99	)	)	PUNCT
aiua-10985	59	100	.	.	PUNCT
aiua-10985	60	1	in	in	ADP
aiua-10985	60	2	dd	dd	PROPN
aiua-10985	60	3	group	group	NOUN
aiua-10985	60	4	,	,	PUNCT
aiua-10985	60	5	the	the	DET
aiua-10985	60	6	mean	mean	NOUN
aiua-10985	60	7	δpv	δpv	VERB
aiua-10985	60	8	values	value	NOUN
aiua-10985	60	9	at	at	ADP
aiua-10985	60	10	1	1	NUM
aiua-10985	60	11	,	,	PUNCT
aiua-10985	60	12	3	3	NUM
aiua-10985	60	13	,	,	PUNCT
aiua-10985	60	14	6	6	NUM
aiua-10985	60	15	,	,	PUNCT
aiua-10985	60	16	12	12	NUM
aiua-10985	60	17	,	,	PUNCT
aiua-10985	60	18	18	18	NUM
aiua-10985	60	19	,	,	PUNCT
aiua-10985	60	20	and	and	CCONJ
aiua-10985	60	21	24	24	NUM
aiua-10985	60	22	months	month	NOUN
aiua-10985	60	23	were	be	AUX
aiua-10985	60	24	+4.1	+4.1	ADJ
aiua-10985	60	25	,	,	PUNCT
aiua-10985	60	26	+2.7	+2.7	PROPN
aiua-10985	60	27	,	,	PUNCT
aiua-10985	60	28	+5.7	+5.7	PROPN
aiua-10985	60	29	,	,	PUNCT
aiua-10985	60	30	+9.2	+9.2	PROPN
aiua-10985	60	31	,	,	PUNCT
aiua-10985	60	32	+11.7	+11.7	PROPN
aiua-10985	60	33	,	,	PUNCT
aiua-10985	60	34	and	and	CCONJ
aiua-10985	60	35	+8.9	+8.9	NUM
aiua-10985	60	36	respectively	respectively	ADV
aiua-10985	60	37	(	(	PUNCT
aiua-10985	60	38	p	p	X
aiua-10985	60	39	=	=	NOUN
aiua-10985	60	40	0.3945	0.3945	NUM
aiua-10985	60	41	)	)	PUNCT
aiua-10985	60	42	.	.	PUNCT
aiua-10985	61	1	the	the	DET
aiua-10985	61	2	reasons	reason	NOUN
aiua-10985	61	3	why	why	SCONJ
aiua-10985	61	4	dutasteride	dutasteride	PROPN
aiua-10985	61	5	was	be	AUX
aiua-10985	61	6	restarted	restart	VERB
aiua-10985	61	7	were	be	AUX
aiua-10985	61	8	as	as	SCONJ
aiua-10985	61	9	follows	follow	VERB
aiua-10985	61	10	:	:	PUNCT
aiua-10985	61	11	choice	choice	NOUN
aiua-10985	61	12	of	of	ADP
aiua-10985	61	13	the	the	DET
aiua-10985	61	14	patient	patient	NOUN
aiua-10985	61	15	in	in	ADP
aiua-10985	61	16	4	4	NUM
aiua-10985	61	17	cases	case	NOUN
aiua-10985	61	18	,	,	PUNCT
aiua-10985	61	19	macrohematuria	macrohematuria	NOUN
aiua-10985	61	20	in	in	ADP
aiua-10985	61	21	2	2	NUM
aiua-10985	61	22	cases	case	NOUN
aiua-10985	61	23	,	,	PUNCT
aiua-10985	61	24	nocturia	nocturia	NOUN
aiua-10985	61	25	in	in	ADP
aiua-10985	61	26	1	1	NUM
aiua-10985	61	27	case	case	NOUN
aiua-10985	61	28	,	,	PUNCT
aiua-10985	61	29	symptom	symptom	NOUN
aiua-10985	61	30	exacerbation	exacerbation	NOUN
aiua-10985	61	31	in	in	ADP
aiua-10985	61	32	4	4	NUM
aiua-10985	61	33	cases	case	NOUN
aiua-10985	61	34	,	,	PUNCT
aiua-10985	61	35	and	and	CCONJ
aiua-10985	61	36	the	the	DET
aiua-10985	61	37	judgment	judgment	NOUN
aiua-10985	61	38	of	of	ADP
aiua-10985	61	39	the	the	DET
aiua-10985	61	40	physician	physician	NOUN
aiua-10985	61	41	in	in	ADP
aiua-10985	61	42	2	2	NUM
aiua-10985	61	43	cases	case	NOUN
aiua-10985	61	44	.	.	PUNCT
aiua-10985	62	1	discussion	discussion	NOUN
aiua-10985	62	2	in	in	ADP
aiua-10985	62	3	the	the	DET
aiua-10985	62	4	present	present	ADJ
aiua-10985	62	5	study	study	NOUN
aiua-10985	62	6	,	,	PUNCT
aiua-10985	62	7	it	it	PRON
aiua-10985	62	8	was	be	AUX
aiua-10985	62	9	suggested	suggest	VERB
aiua-10985	62	10	that	that	SCONJ
aiua-10985	62	11	nocturia	nocturia	PROPN
aiua-10985	62	12	and	and	CCONJ
aiua-10985	62	13	a	a	DET
aiua-10985	62	14	long	long	ADJ
aiua-10985	62	15	period	period	NOUN
aiua-10985	62	16	of	of	ADP
aiua-10985	62	17	dutasteride	dutasteride	PROPN
aiua-10985	62	18	treatment	treatment	NOUN
aiua-10985	62	19	prior	prior	ADV
aiua-10985	62	20	to	to	ADP
aiua-10985	62	21	the	the	DET
aiua-10985	62	22	discontinuation	discontinuation	NOUN
aiua-10985	62	23	of	of	ADP
aiua-10985	62	24	dutasteride	dutasteride	NOUN
aiua-10985	62	25	are	be	AUX
aiua-10985	62	26	predictors	predictor	NOUN
aiua-10985	62	27	of	of	ADP
aiua-10985	62	28	restarting	restart	VERB
aiua-10985	62	29	dutasteride	dutasteride	NOUN
aiua-10985	62	30	in	in	ADP
aiua-10985	62	31	the	the	DET
aiua-10985	62	32	real	real	ADJ
aiua-10985	62	33	-	-	PUNCT
aiua-10985	62	34	world	world	NOUN
aiua-10985	62	35	setting	setting	NOUN
aiua-10985	62	36	.	.	PUNCT
aiua-10985	63	1	consequently	consequently	ADV
aiua-10985	63	2	,	,	PUNCT
aiua-10985	63	3	in	in	ADP
aiua-10985	63	4	patients	patient	NOUN
aiua-10985	63	5	that	that	PRON
aiua-10985	63	6	do	do	AUX
aiua-10985	63	7	not	not	PART
aiua-10985	63	8	exhibit	exhibit	VERB
aiua-10985	63	9	nocturia	nocturia	NOUN
aiua-10985	63	10	before	before	ADP
aiua-10985	63	11	the	the	DET
aiua-10985	63	12	discontinuation	discontinuation	NOUN
aiua-10985	63	13	of	of	ADP
aiua-10985	63	14	dutasteride	dutasteride	NOUN
aiua-10985	63	15	,	,	PUNCT
aiua-10985	63	16	the	the	DET
aiua-10985	63	17	withdrawal	withdrawal	NOUN
aiua-10985	63	18	of	of	ADP
aiua-10985	63	19	dutasteride	dutasteride	NOUN
aiua-10985	63	20	should	should	AUX
aiua-10985	63	21	be	be	AUX
aiua-10985	63	22	considered	consider	VERB
aiua-10985	63	23	feasible	feasible	ADJ
aiua-10985	63	24	.	.	PUNCT
aiua-10985	64	1	discontinuation	discontinuation	NOUN
aiua-10985	64	2	of	of	ADP
aiua-10985	64	3	drugs	drug	NOUN
aiua-10985	64	4	for	for	ADP
aiua-10985	64	5	bph	bph	NOUN
aiua-10985	64	6	treatment	treatment	NOUN
aiua-10985	64	7	there	there	ADV
aiua-10985	64	8	have	have	AUX
aiua-10985	64	9	been	be	AUX
aiua-10985	64	10	a	a	DET
aiua-10985	64	11	few	few	ADJ
aiua-10985	64	12	prospective	prospective	ADJ
aiua-10985	64	13	studies	study	NOUN
aiua-10985	64	14	on	on	ADP
aiua-10985	64	15	the	the	DET
aiua-10985	64	16	discontinuation	discontinuation	NOUN
aiua-10985	64	17	of	of	ADP
aiua-10985	64	18	dutasteride	dutasteride	PROPN
aiua-10985	64	19	.	.	PUNCT
aiua-10985	65	1	shindo	shindo	PROPN
aiua-10985	65	2	et	et	PROPN
aiua-10985	65	3	al	al	PROPN
aiua-10985	65	4	.	.	PROPN
aiua-10985	65	5	evaluated	evaluate	VERB
aiua-10985	65	6	the	the	DET
aiua-10985	65	7	possibility	possibility	NOUN
aiua-10985	65	8	of	of	ADP
aiua-10985	65	9	discontinuing	discontinue	VERB
aiua-10985	65	10	dutasteride	dutasteride	PROPN
aiua-10985	65	11	after	after	SCONJ
aiua-10985	65	12	it	it	PRON
aiua-10985	65	13	was	be	AUX
aiua-10985	65	14	used	use	VERB
aiua-10985	65	15	in	in	ADP
aiua-10985	65	16	combination	combination	NOUN
aiua-10985	65	17	with	with	ADP
aiua-10985	65	18	an	an	DET
aiua-10985	65	19	alpha-1	alpha-1	NUM
aiua-10985	65	20	blocker	blocker	NOUN
aiua-10985	65	21	for	for	ADP
aiua-10985	65	22	bph	bph	NOUN
aiua-10985	65	23	(	(	PUNCT
aiua-10985	65	24	11	11	NUM
aiua-10985	65	25	)	)	PUNCT
aiua-10985	65	26	.	.	PUNCT
aiua-10985	66	1	after	after	ADP
aiua-10985	66	2	6	6	NUM
aiua-10985	66	3	months	month	NOUN
aiua-10985	66	4	of	of	ADP
aiua-10985	66	5	combination	combination	NOUN
aiua-10985	66	6	therapy	therapy	NOUN
aiua-10985	66	7	,	,	PUNCT
aiua-10985	66	8	60	60	NUM
aiua-10985	66	9	%	%	NOUN
aiua-10985	66	10	of	of	ADP
aiua-10985	66	11	the	the	DET
aiua-10985	66	12	patients	patient	NOUN
aiua-10985	66	13	in	in	ADP
aiua-10985	66	14	whom	whom	PRON
aiua-10985	66	15	dutasteride	dutasteride	NOUN
aiua-10985	66	16	was	be	AUX
aiua-10985	66	17	discontinued	discontinue	VERB
aiua-10985	66	18	restarted	restart	VERB
aiua-10985	66	19	taking	take	VERB
aiua-10985	66	20	dutasteride	dutasteride	NOUN
aiua-10985	66	21	within	within	ADP
aiua-10985	66	22	12	12	NUM
aiua-10985	66	23	months	month	NOUN
aiua-10985	66	24	.	.	PUNCT
aiua-10985	67	1	the	the	DET
aiua-10985	67	2	degree	degree	NOUN
aiua-10985	67	3	of	of	ADP
aiua-10985	67	4	prostatic	prostatic	ADJ
aiua-10985	67	5	enlargement	enlargement	NOUN
aiua-10985	67	6	seen	see	VERB
aiua-10985	67	7	after	after	ADP
aiua-10985	67	8	the	the	DET
aiua-10985	67	9	discontinuation	discontinuation	NOUN
aiua-10985	67	10	of	of	ADP
aiua-10985	67	11	dutasteride	dutasteride	NOUN
aiua-10985	67	12	differed	differ	VERB
aiua-10985	67	13	among	among	ADP
aiua-10985	67	14	patients	patient	NOUN
aiua-10985	67	15	.	.	PUNCT
aiua-10985	68	1	according	accord	VERB
aiua-10985	68	2	to	to	ADP
aiua-10985	68	3	this	this	DET
aiua-10985	68	4	study	study	NOUN
aiua-10985	68	5	,	,	PUNCT
aiua-10985	68	6	rapid	rapid	ADJ
aiua-10985	68	7	regrowth	regrowth	NOUN
aiua-10985	68	8	of	of	ADP
aiua-10985	68	9	the	the	DET
aiua-10985	68	10	prostate	prostate	NOUN
aiua-10985	68	11	leads	lead	VERB
aiua-10985	68	12	to	to	ADP
aiua-10985	68	13	the	the	DET
aiua-10985	68	14	deterioration	deterioration	NOUN
aiua-10985	68	15	of	of	ADP
aiua-10985	68	16	storage	storage	NOUN
aiua-10985	68	17	symptoms	symptom	NOUN
aiua-10985	68	18	and	and	CCONJ
aiua-10985	68	19	a	a	DET
aiua-10985	68	20	tendency	tendency	NOUN
aiua-10985	68	21	to	to	PART
aiua-10985	68	22	restart	restart	VERB
aiua-10985	68	23	dutasteride	dutasteride	PROPN
aiua-10985	68	24	and	and	CCONJ
aiua-10985	68	25	the	the	DET
aiua-10985	68	26	baseline	baseline	ADJ
aiua-10985	68	27	intraprostatic	intraprostatic	ADJ
aiua-10985	68	28	architecture	architecture	NOUN
aiua-10985	68	29	may	may	AUX
aiua-10985	68	30	be	be	AUX
aiua-10985	68	31	a	a	DET
aiua-10985	68	32	predictor	predictor	NOUN
aiua-10985	68	33	of	of	ADP
aiua-10985	68	34	whether	whether	SCONJ
aiua-10985	68	35	a	a	DET
aiua-10985	68	36	patient	patient	NOUN
aiua-10985	68	37	is	be	AUX
aiua-10985	68	38	a	a	DET
aiua-10985	68	39	good	good	ADJ
aiua-10985	68	40	candidate	candidate	NOUN
aiua-10985	68	41	for	for	ADP
aiua-10985	68	42	dutasteride	dutasteride	NOUN
aiua-10985	68	43	discontinuation	discontinuation	NOUN
aiua-10985	68	44	.	.	PUNCT
aiua-10985	69	1	victor	victor	PROPN
aiua-10985	69	2	et	et	PROPN
aiua-10985	69	3	al	al	PROPN
aiua-10985	69	4	.	.	PROPN
aiua-10985	69	5	investigated	investigate	VERB
aiua-10985	69	6	the	the	DET
aiua-10985	69	7	outcomes	outcome	NOUN
aiua-10985	69	8	of	of	ADP
aiua-10985	69	9	discontinuing	discontinue	VERB
aiua-10985	69	10	one	one	NUM
aiua-10985	69	11	medication	medication	NOUN
aiua-10985	69	12	after	after	ADP
aiua-10985	69	13	2	2	NUM
aiua-10985	69	14	years	year	NOUN
aiua-10985	69	15	of	of	ADP
aiua-10985	69	16	combined	combined	ADJ
aiua-10985	69	17	alpha	alpha	NOUN
aiua-10985	69	18	-	-	PUNCT
aiua-10985	69	19	blocker	blocker	NOUN
aiua-10985	69	20	and	and	CCONJ
aiua-10985	69	21	5ari	5ari	ADJ
aiua-10985	69	22	therapy	therapy	NOUN
aiua-10985	69	23	for	for	ADP
aiua-10985	69	24	bph	bph	NOUN
aiua-10985	69	25	/	/	SYM
aiua-10985	69	26	luts	luts	PROPN
aiua-10985	69	27	in	in	ADP
aiua-10985	69	28	a	a	DET
aiua-10985	69	29	randomized	randomized	ADJ
aiua-10985	69	30	multicenter	multicenter	NOUN
aiua-10985	69	31	study	study	NOUN
aiua-10985	69	32	(	(	PUNCT
aiua-10985	69	33	13	13	NUM
aiua-10985	69	34	)	)	PUNCT
aiua-10985	69	35	.	.	PUNCT
aiua-10985	70	1	they	they	PRON
aiua-10985	70	2	concluded	conclude	VERB
aiua-10985	70	3	that	that	SCONJ
aiua-10985	70	4	the	the	DET
aiua-10985	70	5	discontinuation	discontinuation	NOUN
aiua-10985	70	6	of	of	ADP
aiua-10985	70	7	either	either	DET
aiua-10985	70	8	drug	drug	NOUN
aiua-10985	70	9	caused	cause	VERB
aiua-10985	70	10	the	the	DET
aiua-10985	70	11	progression	progression	NOUN
aiua-10985	70	12	of	of	ADP
aiua-10985	70	13	bph	bph	NOUN
aiua-10985	70	14	.	.	PUNCT
aiua-10985	71	1	however	however	ADV
aiua-10985	71	2	,	,	PUNCT
aiua-10985	71	3	they	they	PRON
aiua-10985	71	4	suggested	suggest	VERB
aiua-10985	71	5	that	that	SCONJ
aiua-10985	71	6	the	the	DET
aiua-10985	71	7	risk	risk	NOUN
aiua-10985	71	8	of	of	ADP
aiua-10985	71	9	resuming	resume	VERB
aiua-10985	71	10	medication	medication	NOUN
aiua-10985	71	11	or	or	CCONJ
aiua-10985	71	12	undergoing	undergo	VERB
aiua-10985	71	13	transurethral	transurethral	ADJ
aiua-10985	71	14	resection	resection	NOUN
aiua-10985	71	15	of	of	ADP
aiua-10985	71	16	the	the	DET
aiua-10985	71	17	prostate	prostate	NOUN
aiua-10985	71	18	was	be	AUX
aiua-10985	71	19	greater	great	ADJ
aiua-10985	71	20	in	in	ADP
aiua-10985	71	21	patients	patient	NOUN
aiua-10985	71	22	who	who	PRON
aiua-10985	71	23	discontinued	discontinue	VERB
aiua-10985	71	24	5ari	5ari	PROPN
aiua-10985	71	25	.	.	PUNCT
aiua-10985	72	1	jeong	jeong	PROPN
aiua-10985	72	2	et	et	PROPN
aiua-10985	72	3	al	al	PROPN
aiua-10985	72	4	.	.	PROPN
aiua-10985	72	5	reported	report	VERB
aiua-10985	72	6	that	that	SCONJ
aiua-10985	72	7	the	the	DET
aiua-10985	72	8	discontinuation	discontinuation	NOUN
aiua-10985	72	9	of	of	ADP
aiua-10985	72	10	5aris	5aris	NUM
aiua-10985	72	11	during	during	ADP
aiua-10985	72	12	combination	combination	NOUN
aiua-10985	72	13	therapy	therapy	NOUN
aiua-10985	72	14	induced	induce	VERB
aiua-10985	72	15	prostate	prostate	NOUN
aiua-10985	72	16	regrowth	regrowth	NOUN
aiua-10985	72	17	and	and	CCONJ
aiua-10985	72	18	symptom	symptom	NOUN
aiua-10985	72	19	aggravation	aggravation	NOUN
aiua-10985	72	20	in	in	ADP
aiua-10985	72	21	males	male	NOUN
aiua-10985	72	22	with	with	ADP
aiua-10985	72	23	bph	bph	NOUN
aiua-10985	72	24	(	(	PUNCT
aiua-10985	72	25	14	14	NUM
aiua-10985	72	26	)	)	PUNCT
aiua-10985	72	27	.	.	PUNCT
aiua-10985	73	1	therefore	therefore	ADV
aiua-10985	73	2	,	,	PUNCT
aiua-10985	73	3	they	they	PRON
aiua-10985	73	4	suggested	suggest	VERB
aiua-10985	73	5	that	that	SCONJ
aiua-10985	73	6	the	the	DET
aiua-10985	73	7	life	life	NOUN
aiua-10985	73	8	-	-	PUNCT
aiua-10985	73	9	long	long	ADJ
aiua-10985	73	10	use	use	NOUN
aiua-10985	73	11	of	of	ADP
aiua-10985	73	12	5aris	5aris	NUM
aiua-10985	73	13	should	should	AUX
aiua-10985	73	14	be	be	AUX
aiua-10985	73	15	considered	consider	VERB
aiua-10985	73	16	to	to	PART
aiua-10985	73	17	prevent	prevent	VERB
aiua-10985	73	18	bph	bph	NOUN
aiua-10985	73	19	progression	progression	NOUN
aiua-10985	73	20	.	.	PUNCT
aiua-10985	74	1	in	in	ADP
aiua-10985	74	2	the	the	DET
aiua-10985	74	3	current	current	ADJ
aiua-10985	74	4	study	study	NOUN
aiua-10985	74	5	it	it	PRON
aiua-10985	74	6	was	be	AUX
aiua-10985	74	7	demonstrated	demonstrate	VERB
aiua-10985	74	8	that	that	SCONJ
aiua-10985	74	9	the	the	DET
aiua-10985	74	10	temporary	temporary	ADJ
aiua-10985	74	11	discontinuation	discontinuation	NOUN
aiua-10985	74	12	of	of	ADP
aiua-10985	74	13	dutasteride	dutasteride	NOUN
aiua-10985	74	14	was	be	AUX
aiua-10985	74	15	feasible	feasible	ADJ
aiua-10985	74	16	,	,	PUNCT
aiua-10985	74	17	and	and	CCONJ
aiua-10985	74	18	in	in	ADP
aiua-10985	74	19	selected	select	VERB
aiua-10985	74	20	cases	case	NOUN
aiua-10985	74	21	it	it	PRON
aiua-10985	74	22	was	be	AUX
aiua-10985	74	23	possible	possible	ADJ
aiua-10985	74	24	to	to	PART
aiua-10985	74	25	discontinue	discontinue	VERB
aiua-10985	74	26	dutasteride	dutasteride	NOUN
aiua-10985	74	27	for	for	ADP
aiua-10985	74	28	2	2	NUM
aiua-10985	74	29	years	year	NOUN
aiua-10985	74	30	.	.	PUNCT
aiua-10985	75	1	polypharmacy	polypharmacy	NOUN
aiua-10985	75	2	regarding	regard	VERB
aiua-10985	75	3	polypharmacy	polypharmacy	NOUN
aiua-10985	75	4	in	in	ADP
aiua-10985	75	5	the	the	DET
aiua-10985	75	6	elderly	elderly	ADJ
aiua-10985	75	7	,	,	PUNCT
aiua-10985	75	8	it	it	PRON
aiua-10985	75	9	was	be	AUX
aiua-10985	75	10	suggested	suggest	VERB
aiua-10985	75	11	that	that	SCONJ
aiua-10985	75	12	the	the	DET
aiua-10985	75	13	temporary	temporary	ADJ
aiua-10985	75	14	discontinuation	discontinuation	NOUN
aiua-10985	75	15	of	of	ADP
aiua-10985	75	16	medications	medication	NOUN
aiua-10985	75	17	could	could	AUX
aiua-10985	75	18	be	be	AUX
aiua-10985	75	19	a	a	DET
aiua-10985	75	20	good	good	ADJ
aiua-10985	75	21	option	option	NOUN
aiua-10985	75	22	,	,	PUNCT
aiua-10985	75	23	and	and	CCONJ
aiua-10985	75	24	it	it	PRON
aiua-10985	75	25	is	be	AUX
aiua-10985	75	26	expected	expect	VERB
aiua-10985	75	27	that	that	SCONJ
aiua-10985	75	28	reducing	reduce	VERB
aiua-10985	75	29	the	the	DET
aiua-10985	75	30	number	number	NOUN
aiua-10985	75	31	of	of	ADP
aiua-10985	75	32	medications	medication	NOUN
aiua-10985	75	33	being	be	AUX
aiua-10985	75	34	taken	take	VERB
aiua-10985	75	35	could	could	AUX
aiua-10985	75	36	potentially	potentially	ADV
aiua-10985	75	37	reduce	reduce	VERB
aiua-10985	75	38	healthcare	healthcare	NOUN
aiua-10985	75	39	costs	cost	NOUN
aiua-10985	75	40	.	.	PUNCT
aiua-10985	76	1	in	in	ADP
aiua-10985	76	2	the	the	DET
aiua-10985	76	3	present	present	ADJ
aiua-10985	76	4	study	study	NOUN
aiua-10985	76	5	,	,	PUNCT
aiua-10985	76	6	the	the	DET
aiua-10985	76	7	number	number	NOUN
aiua-10985	76	8	of	of	ADP
aiua-10985	76	9	different	different	ADJ
aiua-10985	76	10	types	type	NOUN
aiua-10985	76	11	of	of	ADP
aiua-10985	76	12	oral	oral	ADJ
aiua-10985	76	13	medications	medication	NOUN
aiua-10985	76	14	being	be	AUX
aiua-10985	76	15	taken	take	VERB
aiua-10985	76	16	by	by	ADP
aiua-10985	76	17	the	the	DET
aiua-10985	76	18	patients	patient	NOUN
aiua-10985	76	19	was	be	AUX
aiua-10985	76	20	higher	high	ADJ
aiua-10985	76	21	in	in	ADP
aiua-10985	76	22	the	the	DET
aiua-10985	76	23	dr	dr	PROPN
aiua-10985	76	24	group	group	NOUN
aiua-10985	76	25	.	.	PUNCT
aiua-10985	77	1	basically	basically	ADV
aiua-10985	77	2	,	,	PUNCT
aiua-10985	77	3	it	it	PRON
aiua-10985	77	4	is	be	AUX
aiua-10985	77	5	assumed	assume	VERB
aiua-10985	77	6	that	that	SCONJ
aiua-10985	77	7	patients	patient	NOUN
aiua-10985	77	8	want	want	VERB
aiua-10985	77	9	to	to	PART
aiua-10985	77	10	reduce	reduce	VERB
aiua-10985	77	11	the	the	DET
aiua-10985	77	12	number	number	NOUN
aiua-10985	77	13	of	of	ADP
aiua-10985	77	14	different	different	ADJ
aiua-10985	77	15	types	type	NOUN
aiua-10985	77	16	of	of	ADP
aiua-10985	77	17	oral	oral	ADJ
aiua-10985	77	18	medications	medication	NOUN
aiua-10985	77	19	they	they	PRON
aiua-10985	77	20	are	be	AUX
aiua-10985	77	21	taking	take	VERB
aiua-10985	77	22	,	,	PUNCT
aiua-10985	77	23	and	and	CCONJ
aiua-10985	77	24	hence	hence	ADV
aiua-10985	77	25	,	,	PUNCT
aiua-10985	77	26	to	to	PART
aiua-10985	77	27	maintain	maintain	VERB
aiua-10985	77	28	discontinuation	discontinuation	NOUN
aiua-10985	77	29	.	.	PUNCT
aiua-10985	78	1	however	however	ADV
aiua-10985	78	2	,	,	PUNCT
aiua-10985	78	3	when	when	SCONJ
aiua-10985	78	4	the	the	DET
aiua-10985	78	5	number	number	NOUN
aiua-10985	78	6	of	of	ADP
aiua-10985	78	7	different	different	ADJ
aiua-10985	78	8	types	type	NOUN
aiua-10985	78	9	of	of	ADP
aiua-10985	78	10	oral	oral	ADJ
aiua-10985	78	11	medications	medication	NOUN
aiua-10985	78	12	being	be	AUX
aiua-10985	78	13	taken	take	VERB
aiua-10985	78	14	exceeds	exceed	VERB
aiua-10985	78	15	a	a	DET
aiua-10985	78	16	certain	certain	ADJ
aiua-10985	78	17	level	level	NOUN
aiua-10985	78	18	,	,	PUNCT
aiua-10985	78	19	one	one	NUM
aiua-10985	78	20	less	less	ADJ
aiua-10985	78	21	medication	medication	NOUN
aiua-10985	78	22	does	do	AUX
aiua-10985	78	23	not	not	PART
aiua-10985	78	24	really	really	ADV
aiua-10985	78	25	change	change	VERB
aiua-10985	78	26	the	the	DET
aiua-10985	78	27	patient	patient	NOUN
aiua-10985	78	28	’s	’s	PART
aiua-10985	78	29	condition	condition	NOUN
aiua-10985	78	30	.	.	PUNCT
aiua-10985	79	1	in	in	ADP
aiua-10985	79	2	fact	fact	NOUN
aiua-10985	79	3	,	,	PUNCT
aiua-10985	79	4	the	the	DET
aiua-10985	79	5	restarting	restarting	NOUN
aiua-10985	79	6	of	of	ADP
aiua-10985	79	7	oral	oral	ADJ
aiua-10985	79	8	medications	medication	NOUN
aiua-10985	79	9	may	may	AUX
aiua-10985	79	10	be	be	AUX
aiua-10985	79	11	related	relate	VERB
aiua-10985	79	12	to	to	ADP
aiua-10985	79	13	the	the	DET
aiua-10985	79	14	types	type	NOUN
aiua-10985	79	15	of	of	ADP
aiua-10985	79	16	oral	oral	ADJ
aiua-10985	79	17	medications	medication	NOUN
aiua-10985	79	18	being	be	AUX
aiua-10985	79	19	taken	take	VERB
aiua-10985	79	20	,	,	PUNCT
aiua-10985	79	21	rather	rather	ADV
aiua-10985	79	22	than	than	ADP
aiua-10985	79	23	the	the	DET
aiua-10985	79	24	number	number	NOUN
aiua-10985	79	25	of	of	ADP
aiua-10985	79	26	medications	medication	NOUN
aiua-10985	79	27	being	be	AUX
aiua-10985	79	28	taken	take	VERB
aiua-10985	79	29	by	by	ADP
aiua-10985	79	30	itself	itself	PRON
aiua-10985	79	31	.	.	PUNCT
aiua-10985	80	1	length	length	NOUN
aiua-10985	80	2	of	of	ADP
aiua-10985	80	3	previous	previous	ADJ
aiua-10985	80	4	treatment	treatment	NOUN
aiua-10985	80	5	this	this	DET
aiua-10985	80	6	study	study	NOUN
aiua-10985	80	7	suggested	suggest	VERB
aiua-10985	80	8	that	that	SCONJ
aiua-10985	80	9	a	a	DET
aiua-10985	80	10	longer	long	ADJ
aiua-10985	80	11	period	period	NOUN
aiua-10985	80	12	of	of	ADP
aiua-10985	80	13	dutasteride	dutasteride	NOUN
aiua-10985	80	14	treatment	treatment	NOUN
aiua-10985	80	15	before	before	ADP
aiua-10985	80	16	discontinuation	discontinuation	NOUN
aiua-10985	80	17	was	be	AUX
aiua-10985	80	18	associated	associate	VERB
aiua-10985	80	19	with	with	ADP
aiua-10985	80	20	a	a	DET
aiua-10985	80	21	greater	great	ADJ
aiua-10985	80	22	likelihood	likelihood	NOUN
aiua-10985	80	23	of	of	ADP
aiua-10985	80	24	restarting	restart	VERB
aiua-10985	80	25	dutasteride	dutasteride	NOUN
aiua-10985	80	26	,	,	PUNCT
aiua-10985	80	27	whereas	whereas	SCONJ
aiua-10985	80	28	previous	previous	ADJ
aiua-10985	80	29	administration	administration	NOUN
aiua-10985	80	30	of	of	ADP
aiua-10985	80	31	dutasteride	dutasteride	PROPN
aiua-10985	80	32	for	for	ADP
aiua-10985	80	33	a	a	DET
aiua-10985	80	34	shorter	short	ADJ
aiua-10985	80	35	period	period	NOUN
aiua-10985	80	36	(	(	PUNCT
aiua-10985	80	37	approximately	approximately	ADV
aiua-10985	80	38	2	2	NUM
aiua-10985	80	39	years	year	NOUN
aiua-10985	80	40	)	)	PUNCT
aiua-10985	80	41	was	be	AUX
aiua-10985	80	42	associated	associate	VERB
aiua-10985	80	43	with	with	ADP
aiua-10985	80	44	persistent	persistent	ADJ
aiua-10985	80	45	discontinuation	discontinuation	NOUN
aiua-10985	80	46	of	of	ADP
aiua-10985	80	47	dutasteride	dutasteride	PROPN
aiua-10985	80	48	.	.	PUNCT
aiua-10985	81	1	a	a	DET
aiua-10985	81	2	longer	long	ADJ
aiua-10985	81	3	dutasteride	dutasteride	NOUN
aiua-10985	81	4	treatment	treatment	NOUN
aiua-10985	81	5	before	before	ADP
aiua-10985	81	6	discontinuation	discontinuation	NOUN
aiua-10985	81	7	could	could	AUX
aiua-10985	81	8	be	be	AUX
aiua-10985	81	9	associated	associate	VERB
aiua-10985	81	10	with	with	ADP
aiua-10985	81	11	a	a	DET
aiua-10985	81	12	greater	great	ADJ
aiua-10985	81	13	effect	effect	NOUN
aiua-10985	81	14	of	of	ADP
aiua-10985	81	15	prostate	prostate	NOUN
aiua-10985	81	16	shrinkage	shrinkage	NOUN
aiua-10985	81	17	that	that	PRON
aiua-10985	81	18	could	could	AUX
aiua-10985	81	19	be	be	AUX
aiua-10985	81	20	maintained	maintain	VERB
aiua-10985	81	21	for	for	ADP
aiua-10985	81	22	a	a	DET
aiua-10985	81	23	longer	long	ADJ
aiua-10985	81	24	period	period	NOUN
aiua-10985	81	25	after	after	ADP
aiua-10985	81	26	dutasteride	dutasteride	NOUN
aiua-10985	81	27	discontinuation	discontinuation	NOUN
aiua-10985	81	28	so	so	SCONJ
aiua-10985	81	29	delaying	delay	VERB
aiua-10985	81	30	restarting	restarting	NOUN
aiua-10985	81	31	of	of	ADP
aiua-10985	81	32	dutasteride	dutasteride	PROPN
aiua-10985	81	33	treatment	treatment	NOUN
aiua-10985	81	34	,	,	PUNCT
aiua-10985	81	35	on	on	ADP
aiua-10985	81	36	the	the	DET
aiua-10985	81	37	contrary	contrary	NOUN
aiua-10985	81	38	we	we	PRON
aiua-10985	81	39	observed	observe	VERB
aiua-10985	81	40	the	the	DET
aiua-10985	81	41	opposite	opposite	NOUN
aiua-10985	81	42	in	in	ADP
aiua-10985	81	43	this	this	DET
aiua-10985	81	44	study	study	NOUN
aiua-10985	81	45	.	.	PUNCT
aiua-10985	82	1	it	it	PRON
aiua-10985	82	2	has	have	AUX
aiua-10985	82	3	been	be	AUX
aiua-10985	82	4	reported	report	VERB
aiua-10985	82	5	that	that	SCONJ
aiua-10985	82	6	the	the	DET
aiua-10985	82	7	main	main	ADJ
aiua-10985	82	8	reason	reason	NOUN
aiua-10985	82	9	for	for	ADP
aiua-10985	82	10	restarting	restart	VERB
aiua-10985	82	11	dutasteride	dutasteride	NOUN
aiua-10985	82	12	is	be	AUX
aiua-10985	82	13	the	the	DET
aiua-10985	82	14	regrowth	regrowth	NOUN
aiua-10985	82	15	of	of	ADP
aiua-10985	82	16	the	the	DET
aiua-10985	82	17	prostate	prostate	NOUN
aiua-10985	82	18	due	due	ADP
aiua-10985	82	19	to	to	ADP
aiua-10985	82	20	the	the	DET
aiua-10985	82	21	discontinuation	discontinuation	NOUN
aiua-10985	82	22	of	of	ADP
aiua-10985	82	23	the	the	DET
aiua-10985	82	24	drug	drug	NOUN
aiua-10985	82	25	(	(	PUNCT
aiua-10985	82	26	11	11	NUM
aiua-10985	82	27	)	)	PUNCT
aiua-10985	82	28	although	although	SCONJ
aiua-10985	82	29	in	in	ADP
aiua-10985	82	30	this	this	DET
aiua-10985	82	31	study	study	NOUN
aiua-10985	82	32	dutasteride	dutasteride	NOUN
aiua-10985	82	33	was	be	AUX
aiua-10985	82	34	mainly	mainly	ADV
aiua-10985	82	35	restarted	restart	VERB
aiua-10985	82	36	because	because	SCONJ
aiua-10985	82	37	of	of	ADP
aiua-10985	82	38	hematuria	hematuria	NOUN
aiua-10985	82	39	or	or	CCONJ
aiua-10985	82	40	the	the	DET
aiua-10985	82	41	choice	choice	NOUN
aiua-10985	82	42	of	of	ADP
aiua-10985	82	43	the	the	DET
aiua-10985	82	44	patient	patient	NOUN
aiua-10985	82	45	.	.	PUNCT
aiua-10985	83	1	nocturia	nocturia	PROPN
aiua-10985	83	2	nocturia	nocturia	PROPN
aiua-10985	83	3	before	before	SCONJ
aiua-10985	83	4	the	the	DET
aiua-10985	83	5	discontinuation	discontinuation	NOUN
aiua-10985	83	6	of	of	ADP
aiua-10985	83	7	dutasteride	dutasteride	NOUN
aiua-10985	83	8	was	be	AUX
aiua-10985	83	9	identified	identify	VERB
aiua-10985	83	10	as	as	ADP
aiua-10985	83	11	another	another	DET
aiua-10985	83	12	predictor	predictor	NOUN
aiua-10985	83	13	of	of	ADP
aiua-10985	83	14	restarting	restart	VERB
aiua-10985	83	15	dutasteride	dutasteride	PROPN
aiua-10985	83	16	treatment	treatment	NOUN
aiua-10985	83	17	.	.	PUNCT
aiua-10985	84	1	in	in	ADP
aiua-10985	84	2	a	a	DET
aiua-10985	84	3	recent	recent	ADJ
aiua-10985	84	4	study	study	NOUN
aiua-10985	84	5	involving	involve	VERB
aiua-10985	84	6	a	a	DET
aiua-10985	84	7	follow	follow	VERB
aiua-10985	84	8	-	-	PUNCT
aiua-10985	84	9	up	up	NOUN
aiua-10985	84	10	period	period	NOUN
aiua-10985	84	11	up	up	ADP
aiua-10985	84	12	to	to	PART
aiua-10985	84	13	21	21	NUM
aiua-10985	84	14	years	year	NOUN
aiua-10985	84	15	,	,	PUNCT
aiua-10985	84	16	it	it	PRON
aiua-10985	84	17	was	be	AUX
aiua-10985	84	18	reported	report	VERB
aiua-10985	84	19	that	that	SCONJ
aiua-10985	84	20	males	male	NOUN
aiua-10985	84	21	with	with	ADP
aiua-10985	84	22	bph	bph	NOUN
aiua-10985	84	23	have	have	VERB
aiua-10985	84	24	a	a	DET
aiua-10985	84	25	persistently	persistently	ADV
aiua-10985	84	26	higher	high	ADJ
aiua-10985	84	27	risk	risk	NOUN
aiua-10985	84	28	of	of	ADP
aiua-10985	84	29	alzheimer	alzheimer	PROPN
aiua-10985	84	30	’s	’s	PART
aiua-10985	84	31	disease	disease	NOUN
aiua-10985	84	32	and	and	CCONJ
aiua-10985	84	33	all	all	DET
aiua-10985	84	34	-	-	PUNCT
aiua-10985	84	35	cause	cause	NOUN
aiua-10985	84	36	dementia	dementia	NOUN
aiua-10985	84	37	compared	compare	VERB
aiua-10985	84	38	with	with	ADP
aiua-10985	84	39	males	male	NOUN
aiua-10985	84	40	in	in	ADP
aiua-10985	84	41	the	the	DET
aiua-10985	84	42	general	general	ADJ
aiua-10985	84	43	population	population	NOUN
aiua-10985	84	44	(	(	PUNCT
aiua-10985	84	45	15	15	NUM
aiua-10985	84	46	)	)	PUNCT
aiua-10985	84	47	.	.	PUNCT
aiua-10985	85	1	the	the	DET
aiua-10985	85	2	study	study	NOUN
aiua-10985	85	3	identified	identify	VERB
aiua-10985	85	4	bph	bph	NOUN
aiua-10985	85	5	(	(	PUNCT
aiua-10985	85	6	and	and	CCONJ
aiua-10985	85	7	associated	associate	VERB
aiua-10985	85	8	sleep	sleep	NOUN
aiua-10985	85	9	disturbances	disturbance	NOUN
aiua-10985	85	10	)	)	PUNCT
aiua-10985	85	11	as	as	ADP
aiua-10985	85	12	a	a	DET
aiua-10985	85	13	common	common	ADJ
aiua-10985	85	14	,	,	PUNCT
aiua-10985	85	15	potentially	potentially	ADV
aiua-10985	85	16	curable	curable	ADJ
aiua-10985	85	17	,	,	PUNCT
aiua-10985	85	18	disorder	disorder	NOUN
aiua-10985	85	19	associated	associate	VERB
aiua-10985	85	20	with	with	ADP
aiua-10985	85	21	dementia	dementia	NOUN
aiua-10985	85	22	risk	risk	NOUN
aiua-10985	85	23	.	.	PUNCT
aiua-10985	86	1	therefore	therefore	ADV
aiua-10985	86	2	,	,	PUNCT
aiua-10985	86	3	it	it	PRON
aiua-10985	86	4	seems	seem	VERB
aiua-10985	86	5	that	that	SCONJ
aiua-10985	86	6	controlling	control	VERB
aiua-10985	86	7	nocturia	nocturia	PROPN
aiua-10985	86	8	is	be	AUX
aiua-10985	86	9	an	an	DET
aiua-10985	86	10	important	important	ADJ
aiua-10985	86	11	issue	issue	NOUN
aiua-10985	86	12	for	for	ADP
aiua-10985	86	13	urologists	urologist	NOUN
aiua-10985	86	14	.	.	PUNCT
aiua-10985	87	1	risk	risk	NOUN
aiua-10985	87	2	of	of	ADP
aiua-10985	87	3	depression	depression	NOUN
aiua-10985	87	4	moreover	moreover	ADV
aiua-10985	87	5	,	,	PUNCT
aiua-10985	87	6	it	it	PRON
aiua-10985	87	7	is	be	AUX
aiua-10985	87	8	important	important	ADJ
aiua-10985	87	9	to	to	PART
aiua-10985	87	10	prescribe	prescribe	VERB
aiua-10985	87	11	appropriate	appropriate	ADJ
aiua-10985	87	12	medication	medication	NOUN
aiua-10985	87	13	.	.	PUNCT
aiua-10985	88	1	associations	association	NOUN
aiua-10985	88	2	between	between	ADP
aiua-10985	88	3	5aris	5aris	NUM
aiua-10985	88	4	and	and	CCONJ
aiua-10985	88	5	suicidality	suicidality	NOUN
aiua-10985	88	6	and	and	CCONJ
aiua-10985	88	7	depression	depression	NOUN
aiua-10985	88	8	have	have	AUX
aiua-10985	88	9	been	be	AUX
aiua-10985	88	10	reported	report	VERB
aiua-10985	88	11	.	.	PUNCT
aiua-10985	89	1	in	in	ADP
aiua-10985	89	2	a	a	DET
aiua-10985	89	3	large	large	ADJ
aiua-10985	89	4	cohort	cohort	NOUN
aiua-10985	89	5	of	of	ADP
aiua-10985	89	6	males	male	NOUN
aiua-10985	89	7	aged	age	VERB
aiua-10985	89	8	≥	≥	NUM
aiua-10985	89	9	66	66	NUM
aiua-10985	89	10	years	year	NOUN
aiua-10985	89	11	,	,	PUNCT
aiua-10985	89	12	it	it	PRON
aiua-10985	89	13	was	be	AUX
aiua-10985	89	14	found	find	VERB
aiua-10985	89	15	that	that	SCONJ
aiua-10985	89	16	the	the	DET
aiua-10985	89	17	risk	risk	NOUN
aiua-10985	89	18	of	of	ADP
aiua-10985	89	19	self	self	NOUN
aiua-10985	89	20	-	-	PUNCT
aiua-10985	89	21	harm	harm	NOUN
aiua-10985	89	22	and	and	CCONJ
aiua-10985	89	23	depression	depression	NOUN
aiua-10985	89	24	were	be	AUX
aiua-10985	89	25	higher	high	ADJ
aiua-10985	89	26	than	than	ADP
aiua-10985	89	27	in	in	ADP
aiua-10985	89	28	males	male	NOUN
aiua-10985	89	29	that	that	PRON
aiua-10985	89	30	were	be	AUX
aiua-10985	89	31	treated	treat	VERB
aiua-10985	89	32	with	with	ADP
aiua-10985	89	33	5aris	5aris	NUM
aiua-10985	89	34	.	.	PUNCT
aiua-10985	90	1	therefore	therefore	ADV
aiua-10985	90	2	,	,	PUNCT
aiua-10985	90	3	it	it	PRON
aiua-10985	90	4	was	be	AUX
aiua-10985	90	5	suggested	suggest	VERB
aiua-10985	90	6	that	that	SCONJ
aiua-10985	90	7	the	the	DET
aiua-10985	90	8	discontinuation	discontinuation	NOUN
aiua-10985	90	9	of	of	ADP
aiua-10985	90	10	5aris	5aris	NUM
aiua-10985	90	11	in	in	ADP
aiua-10985	90	12	these	these	DET
aiua-10985	90	13	circumstances	circumstance	NOUN
aiua-10985	90	14	may	may	AUX
aiua-10985	90	15	be	be	AUX
aiua-10985	90	16	appropriate	appropriate	ADJ
aiua-10985	90	17	(	(	PUNCT
aiua-10985	90	18	12	12	NUM
aiua-10985	90	19	)	)	PUNCT
aiua-10985	90	20	.	.	PUNCT
aiua-10985	91	1	archivio	archivio	NOUN
aiua-10985	91	2	italiano	italiano	PROPN
aiua-10985	91	3	di	di	X
aiua-10985	91	4	urologia	urologia	PROPN
aiua-10985	91	5	e	e	PROPN
aiua-10985	91	6	andrologia	andrologia	PROPN
aiua-10985	91	7	2022	2022	NUM
aiua-10985	91	8	;	;	PUNCT
aiua-10985	91	9	94	94	NUM
aiua-10985	91	10	,	,	PUNCT
aiua-10985	91	11	4	4	NUM
aiua-10985	91	12	h.	h.	PROPN
aiua-10985	91	13	masuda	masuda	PROPN
aiua-10985	91	14	,	,	PUNCT
aiua-10985	91	15	k.	k.	PROPN
aiua-10985	91	16	mikami	mikami	PROPN
aiua-10985	91	17	,	,	PUNCT
aiua-10985	91	18	k.	k.	PROPN
aiua-10985	91	19	otsuka	otsuka	PROPN
aiua-10985	91	20	,	,	PUNCT
aiua-10985	91	21	k.	k.	PROPN
aiua-10985	91	22	hou	hou	PROPN
aiua-10985	91	23	,	,	PUNCT
aiua-10985	91	24	t.	t.	NOUN
aiua-10985	91	25	suyama	suyama	NOUN
aiua-10985	91	26	,	,	PUNCT
aiua-10985	91	27	k.	k.	PROPN
aiua-10985	91	28	araki	araki	PROPN
aiua-10985	91	29	,	,	PUNCT
aiua-10985	91	30	s.	s.	PROPN
aiua-10985	91	31	kojima	kojima	PROPN
aiua-10985	91	32	,	,	PUNCT
aiua-10985	91	33	y.	y.	PROPN
aiua-10985	91	34	naya	naya	PROPN
aiua-10985	91	35	524	524	NUM
aiua-10985	91	36	limitations	limitation	NOUN
aiua-10985	91	37	we	we	PRON
aiua-10985	91	38	would	would	AUX
aiua-10985	91	39	like	like	VERB
aiua-10985	91	40	to	to	PART
aiua-10985	91	41	emphasize	emphasize	VERB
aiua-10985	91	42	several	several	ADJ
aiua-10985	91	43	limitations	limitation	NOUN
aiua-10985	91	44	of	of	ADP
aiua-10985	91	45	our	our	PRON
aiua-10985	91	46	study	study	NOUN
aiua-10985	91	47	.	.	PUNCT
aiua-10985	92	1	firstly	firstly	ADV
aiua-10985	92	2	,	,	PUNCT
aiua-10985	92	3	it	it	PRON
aiua-10985	92	4	was	be	AUX
aiua-10985	92	5	a	a	DET
aiua-10985	92	6	retrospective	retrospective	ADJ
aiua-10985	92	7	cohort	cohort	NOUN
aiua-10985	92	8	study	study	NOUN
aiua-10985	92	9	,	,	PUNCT
aiua-10985	92	10	which	which	PRON
aiua-10985	92	11	involved	involve	VERB
aiua-10985	92	12	the	the	DET
aiua-10985	92	13	extraction	extraction	NOUN
aiua-10985	92	14	of	of	ADP
aiua-10985	92	15	electronically	electronically	ADV
aiua-10985	92	16	stored	store	VERB
aiua-10985	92	17	clinical	clinical	ADJ
aiua-10985	92	18	data	datum	NOUN
aiua-10985	92	19	,	,	PUNCT
aiua-10985	92	20	and	and	CCONJ
aiua-10985	92	21	it	it	PRON
aiua-10985	92	22	had	have	VERB
aiua-10985	92	23	a	a	DET
aiua-10985	92	24	small	small	ADJ
aiua-10985	92	25	sample	sample	NOUN
aiua-10985	92	26	size	size	NOUN
aiua-10985	92	27	.	.	PUNCT
aiua-10985	93	1	secondly	secondly	ADV
aiua-10985	93	2	,	,	PUNCT
aiua-10985	93	3	we	we	PRON
aiua-10985	93	4	could	could	AUX
aiua-10985	93	5	not	not	PART
aiua-10985	93	6	assess	assess	VERB
aiua-10985	93	7	the	the	DET
aiua-10985	93	8	effects	effect	NOUN
aiua-10985	93	9	of	of	ADP
aiua-10985	93	10	the	the	DET
aiua-10985	93	11	discontinuation	discontinuation	NOUN
aiua-10985	93	12	of	of	ADP
aiua-10985	93	13	dutasteride	dutasteride	NOUN
aiua-10985	93	14	on	on	ADP
aiua-10985	93	15	qol	qol	NOUN
aiua-10985	93	16	.	.	PUNCT
aiua-10985	94	1	thirdly	thirdly	ADV
aiua-10985	94	2	,	,	PUNCT
aiua-10985	94	3	we	we	PRON
aiua-10985	94	4	examined	examine	VERB
aiua-10985	94	5	the	the	DET
aiua-10985	94	6	types	type	NOUN
aiua-10985	94	7	of	of	ADP
aiua-10985	94	8	other	other	ADJ
aiua-10985	94	9	medications	medication	NOUN
aiua-10985	94	10	(	(	PUNCT
aiua-10985	94	11	in	in	ADP
aiua-10985	94	12	general	general	ADJ
aiua-10985	94	13	)	)	PUNCT
aiua-10985	94	14	the	the	DET
aiua-10985	94	15	patients	patient	NOUN
aiua-10985	94	16	were	be	AUX
aiua-10985	94	17	taking	take	VERB
aiua-10985	94	18	,	,	PUNCT
aiua-10985	94	19	but	but	CCONJ
aiua-10985	94	20	we	we	PRON
aiua-10985	94	21	should	should	AUX
aiua-10985	94	22	also	also	ADV
aiua-10985	94	23	have	have	AUX
aiua-10985	94	24	examined	examine	VERB
aiua-10985	94	25	the	the	DET
aiua-10985	94	26	actual	actual	ADJ
aiua-10985	94	27	daily	daily	ADJ
aiua-10985	94	28	amounts	amount	NOUN
aiua-10985	94	29	of	of	ADP
aiua-10985	94	30	other	other	ADJ
aiua-10985	94	31	medications	medication	NOUN
aiua-10985	94	32	that	that	PRON
aiua-10985	94	33	they	they	PRON
aiua-10985	94	34	were	be	AUX
aiua-10985	94	35	taking	take	VERB
aiua-10985	94	36	.	.	PUNCT
aiua-10985	95	1	it	it	PRON
aiua-10985	95	2	was	be	AUX
aiua-10985	95	3	suggested	suggest	VERB
aiua-10985	95	4	that	that	SCONJ
aiua-10985	95	5	if	if	SCONJ
aiua-10985	95	6	the	the	DET
aiua-10985	95	7	daily	daily	ADJ
aiua-10985	95	8	amounts	amount	NOUN
aiua-10985	95	9	of	of	ADP
aiua-10985	95	10	other	other	ADJ
aiua-10985	95	11	medications	medication	NOUN
aiua-10985	95	12	being	be	AUX
aiua-10985	95	13	taken	take	VERB
aiua-10985	95	14	by	by	ADP
aiua-10985	95	15	a	a	DET
aiua-10985	95	16	patient	patient	NOUN
aiua-10985	95	17	is	be	AUX
aiua-10985	95	18	high	high	ADJ
aiua-10985	95	19	,	,	PUNCT
aiua-10985	95	20	the	the	DET
aiua-10985	95	21	patient	patient	NOUN
aiua-10985	95	22	may	may	AUX
aiua-10985	95	23	not	not	PART
aiua-10985	95	24	restart	restart	VERB
aiua-10985	95	25	taking	take	VERB
aiua-10985	95	26	discontinued	discontinue	VERB
aiua-10985	95	27	medications	medication	NOUN
aiua-10985	95	28	because	because	SCONJ
aiua-10985	95	29	they	they	PRON
aiua-10985	95	30	may	may	AUX
aiua-10985	95	31	want	want	VERB
aiua-10985	95	32	to	to	PART
aiua-10985	95	33	reduce	reduce	VERB
aiua-10985	95	34	the	the	DET
aiua-10985	95	35	daily	daily	ADJ
aiua-10985	95	36	amounts	amount	NOUN
aiua-10985	95	37	of	of	ADP
aiua-10985	95	38	other	other	ADJ
aiua-10985	95	39	medication	medication	NOUN
aiua-10985	95	40	that	that	PRON
aiua-10985	95	41	they	they	PRON
aiua-10985	95	42	are	be	AUX
aiua-10985	95	43	taking	take	VERB
aiua-10985	95	44	.	.	PUNCT
aiua-10985	96	1	conclusions	conclusion	NOUN
aiua-10985	96	2	the	the	DET
aiua-10985	96	3	present	present	ADJ
aiua-10985	96	4	study	study	NOUN
aiua-10985	96	5	suggested	suggest	VERB
aiua-10985	96	6	that	that	SCONJ
aiua-10985	96	7	the	the	DET
aiua-10985	96	8	temporary	temporary	ADJ
aiua-10985	96	9	discontinuation	discontinuation	NOUN
aiua-10985	96	10	of	of	ADP
aiua-10985	96	11	dutasteride	dutasteride	NOUN
aiua-10985	96	12	can	can	AUX
aiua-10985	96	13	be	be	AUX
aiua-10985	96	14	considered	consider	VERB
aiua-10985	96	15	in	in	ADP
aiua-10985	96	16	cases	case	NOUN
aiua-10985	96	17	who	who	PRON
aiua-10985	96	18	present	present	VERB
aiua-10985	96	19	a	a	DET
aiua-10985	96	20	low	low	ADJ
aiua-10985	96	21	frequency	frequency	NOUN
aiua-10985	96	22	of	of	ADP
aiua-10985	96	23	nocturia	nocturia	PROPN
aiua-10985	96	24	and	and	CCONJ
aiua-10985	96	25	a	a	DET
aiua-10985	96	26	relatively	relatively	ADV
aiua-10985	96	27	short	short	ADJ
aiua-10985	96	28	period	period	NOUN
aiua-10985	96	29	of	of	ADP
aiua-10985	96	30	dutasteride	dutasteride	NOUN
aiua-10985	96	31	treatment	treatment	NOUN
aiua-10985	96	32	before	before	ADP
aiua-10985	96	33	discontinuation	discontinuation	NOUN
aiua-10985	96	34	.	.	PUNCT
aiua-10985	97	1	in	in	ADP
aiua-10985	97	2	addition	addition	NOUN
aiua-10985	97	3	,	,	PUNCT
aiua-10985	97	4	temporary	temporary	ADJ
aiua-10985	97	5	discontinuation	discontinuation	NOUN
aiua-10985	97	6	of	of	ADP
aiua-10985	97	7	dutasteride	dutasteride	NOUN
aiua-10985	97	8	may	may	AUX
aiua-10985	97	9	be	be	AUX
aiua-10985	97	10	useful	useful	ADJ
aiua-10985	97	11	for	for	ADP
aiua-10985	97	12	dealing	deal	VERB
aiua-10985	97	13	with	with	ADP
aiua-10985	97	14	polypharmacy	polypharmacy	NOUN
aiua-10985	97	15	in	in	ADP
aiua-10985	97	16	the	the	DET
aiua-10985	97	17	elderly	elderly	ADJ
aiua-10985	97	18	.	.	PUNCT
aiua-10985	98	1	references	reference	NOUN
aiua-10985	98	2	1	1	NUM
aiua-10985	98	3	.	.	PUNCT
aiua-10985	98	4	gratzke	gratzke	PROPN
aiua-10985	98	5	c	c	PROPN
aiua-10985	98	6	,	,	PUNCT
aiua-10985	98	7	bachmann	bachmann	PROPN
aiua-10985	98	8	a	a	PRON
aiua-10985	98	9	,	,	PUNCT
aiua-10985	98	10	descazeaud	descazeaud	VERB
aiua-10985	98	11	a	a	PRON
aiua-10985	98	12	,	,	PUNCT
aiua-10985	98	13	et	et	PROPN
aiua-10985	98	14	al	al	PROPN
aiua-10985	98	15	.	.	PUNCT
aiua-10985	99	1	eau	eau	PROPN
aiua-10985	99	2	guidelines	guideline	NOUN
aiua-10985	99	3	on	on	ADP
aiua-10985	99	4	the	the	DET
aiua-10985	99	5	assessment	assessment	NOUN
aiua-10985	99	6	of	of	ADP
aiua-10985	99	7	non	non	ADJ
aiua-10985	99	8	-	-	ADJ
aiua-10985	99	9	neurogenic	neurogenic	ADJ
aiua-10985	99	10	male	male	NOUN
aiua-10985	99	11	lower	low	ADJ
aiua-10985	99	12	urinary	urinary	ADJ
aiua-10985	99	13	tract	tract	NOUN
aiua-10985	99	14	symptoms	symptom	NOUN
aiua-10985	99	15	including	include	VERB
aiua-10985	99	16	benign	benign	ADJ
aiua-10985	99	17	prostatic	prostatic	ADJ
aiua-10985	99	18	obstruction	obstruction	NOUN
aiua-10985	99	19	.	.	PUNCT
aiua-10985	100	1	eur	eur	PROPN
aiua-10985	100	2	urol	urol	PROPN
aiua-10985	100	3	.	.	PUNCT
aiua-10985	101	1	2015	2015	NUM
aiua-10985	101	2	;	;	PUNCT
aiua-10985	101	3	67:1099	67:1099	X
aiua-10985	101	4	-	-	SYM
aiua-10985	101	5	1109	1109	NUM
aiua-10985	101	6	.	.	PUNCT
aiua-10985	102	1	2	2	X
aiua-10985	102	2	.	.	X
aiua-10985	102	3	mcconnell	mcconnell	PROPN
aiua-10985	102	4	jd	jd	PROPN
aiua-10985	102	5	,	,	PUNCT
aiua-10985	102	6	roehrborn	roehrborn	ADJ
aiua-10985	102	7	cg	cg	NOUN
aiua-10985	102	8	,	,	PUNCT
aiua-10985	102	9	bautista	bautista	PROPN
aiua-10985	102	10	om	om	PROPN
aiua-10985	102	11	,	,	PUNCT
aiua-10985	102	12	et	et	PROPN
aiua-10985	102	13	al	al	PROPN
aiua-10985	102	14	.	.	PUNCT
aiua-10985	102	15	medical	medical	ADJ
aiua-10985	102	16	therapy	therapy	NOUN
aiua-10985	102	17	of	of	ADP
aiua-10985	102	18	prostatic	prostatic	ADJ
aiua-10985	102	19	symptoms	symptom	NOUN
aiua-10985	102	20	(	(	PUNCT
aiua-10985	102	21	mtops	mtop	NOUN
aiua-10985	102	22	)	)	PUNCT
aiua-10985	102	23	research	research	NOUN
aiua-10985	102	24	group	group	NOUN
aiua-10985	102	25	:	:	PUNCT
aiua-10985	102	26	the	the	DET
aiua-10985	102	27	long	long	ADJ
aiua-10985	102	28	-	-	PUNCT
aiua-10985	102	29	term	term	NOUN
aiua-10985	102	30	effect	effect	NOUN
aiua-10985	102	31	of	of	ADP
aiua-10985	102	32	doxazosin	doxazosin	PROPN
aiua-10985	102	33	,	,	PUNCT
aiua-10985	102	34	finasteride	finasteride	ADJ
aiua-10985	102	35	,	,	PUNCT
aiua-10985	102	36	and	and	CCONJ
aiua-10985	102	37	combination	combination	NOUN
aiua-10985	102	38	therapy	therapy	NOUN
aiua-10985	102	39	on	on	ADP
aiua-10985	102	40	the	the	DET
aiua-10985	102	41	clinical	clinical	ADJ
aiua-10985	102	42	progression	progression	NOUN
aiua-10985	102	43	of	of	ADP
aiua-10985	102	44	benign	benign	ADJ
aiua-10985	102	45	prostatic	prostatic	ADJ
aiua-10985	102	46	hyperplasia	hyperplasia	NOUN
aiua-10985	102	47	.	.	PUNCT
aiua-10985	103	1	n	n	PROPN
aiua-10985	103	2	eng	eng	PROPN
aiua-10985	103	3	j	j	PROPN
aiua-10985	103	4	med	med	PROPN
aiua-10985	103	5	.	.	PUNCT
aiua-10985	103	6	2003	2003	NUM
aiua-10985	103	7	;	;	PUNCT
aiua-10985	103	8	349:2387	349:2387	NUM
aiua-10985	103	9	-	-	SYM
aiua-10985	103	10	2398	2398	NUM
aiua-10985	103	11	.	.	PUNCT
aiua-10985	104	1	3	3	X
aiua-10985	104	2	.	.	X
aiua-10985	104	3	roehrborn	roehrborn	ADJ
aiua-10985	104	4	cg	cg	NOUN
aiua-10985	104	5	,	,	PUNCT
aiua-10985	104	6	siami	siami	VERB
aiua-10985	104	7	p	p	NOUN
aiua-10985	104	8	,	,	PUNCT
aiua-10985	104	9	barkin	barkin	PROPN
aiua-10985	104	10	j	j	PROPN
aiua-10985	104	11	,	,	PUNCT
aiua-10985	104	12	et	et	PROPN
aiua-10985	104	13	al	al	PROPN
aiua-10985	104	14	.	.	PUNCT
aiua-10985	105	1	combat	combat	PROPN
aiua-10985	105	2	study	study	NOUN
aiua-10985	105	3	group	group	NOUN
aiua-10985	105	4	:	:	PUNCT
aiua-10985	105	5	the	the	DET
aiua-10985	105	6	effects	effect	NOUN
aiua-10985	105	7	of	of	ADP
aiua-10985	105	8	dutasteride	dutasteride	NOUN
aiua-10985	105	9	,	,	PUNCT
aiua-10985	105	10	tamsulosin	tamsulosin	NOUN
aiua-10985	105	11	and	and	CCONJ
aiua-10985	105	12	combination	combination	NOUN
aiua-10985	105	13	therapy	therapy	NOUN
aiua-10985	105	14	on	on	ADP
aiua-10985	105	15	lower	low	ADJ
aiua-10985	105	16	urinary	urinary	ADJ
aiua-10985	105	17	tract	tract	NOUN
aiua-10985	105	18	symptoms	symptom	NOUN
aiua-10985	105	19	in	in	ADP
aiua-10985	105	20	men	man	NOUN
aiua-10985	105	21	with	with	ADP
aiua-10985	105	22	benign	benign	ADJ
aiua-10985	105	23	prostatic	prostatic	ADJ
aiua-10985	105	24	hyperplasia	hyperplasia	NOUN
aiua-10985	105	25	and	and	CCONJ
aiua-10985	105	26	prostatic	prostatic	ADJ
aiua-10985	105	27	enlargement	enlargement	NOUN
aiua-10985	105	28	:	:	PUNCT
aiua-10985	105	29	2	2	NUM
aiua-10985	105	30	-	-	PUNCT
aiua-10985	105	31	year	year	NOUN
aiua-10985	105	32	results	result	NOUN
aiua-10985	105	33	from	from	ADP
aiua-10985	105	34	the	the	DET
aiua-10985	105	35	combat	combat	NOUN
aiua-10985	105	36	study	study	NOUN
aiua-10985	105	37	.	.	PUNCT
aiua-10985	106	1	j	j	PROPN
aiua-10985	106	2	urol	urol	PROPN
aiua-10985	106	3	.	.	PUNCT
aiua-10985	106	4	2008	2008	NUM
aiua-10985	106	5	;	;	PUNCT
aiua-10985	106	6	179:616	179:616	NOUN
aiua-10985	106	7	-	-	PUNCT
aiua-10985	106	8	621	621	NUM
aiua-10985	106	9	.	.	PUNCT
aiua-10985	107	1	4	4	X
aiua-10985	107	2	.	.	X
aiua-10985	107	3	roehrborn	roehrborn	ADJ
aiua-10985	107	4	cg	cg	NOUN
aiua-10985	107	5	,	,	PUNCT
aiua-10985	107	6	siami	siami	VERB
aiua-10985	107	7	p	p	NOUN
aiua-10985	107	8	,	,	PUNCT
aiua-10985	107	9	barkin	barkin	PROPN
aiua-10985	107	10	j	j	PROPN
aiua-10985	107	11	,	,	PUNCT
aiua-10985	107	12	et	et	PROPN
aiua-10985	107	13	al	al	PROPN
aiua-10985	107	14	.	.	PUNCT
aiua-10985	108	1	combat	combat	PROPN
aiua-10985	108	2	study	study	NOUN
aiua-10985	108	3	group	group	NOUN
aiua-10985	108	4	:	:	PUNCT
aiua-10985	108	5	the	the	DET
aiua-10985	108	6	influence	influence	NOUN
aiua-10985	108	7	of	of	ADP
aiua-10985	108	8	baseline	baseline	ADJ
aiua-10985	108	9	parameters	parameter	NOUN
aiua-10985	108	10	on	on	ADP
aiua-10985	108	11	changes	change	NOUN
aiua-10985	108	12	in	in	ADP
aiua-10985	108	13	international	international	ADJ
aiua-10985	108	14	prostate	prostate	NOUN
aiua-10985	108	15	symptom	symptom	NOUN
aiua-10985	108	16	score	score	NOUN
aiua-10985	108	17	with	with	ADP
aiua-10985	108	18	dutasteride	dutasteride	NOUN
aiua-10985	108	19	,	,	PUNCT
aiua-10985	108	20	tamsulosin	tamsulosin	NOUN
aiua-10985	108	21	,	,	PUNCT
aiua-10985	108	22	and	and	CCONJ
aiua-10985	108	23	combination	combination	NOUN
aiua-10985	108	24	therapy	therapy	NOUN
aiua-10985	108	25	among	among	ADP
aiua-10985	108	26	men	man	NOUN
aiua-10985	108	27	with	with	ADP
aiua-10985	108	28	symptomatic	symptomatic	ADJ
aiua-10985	108	29	benign	benign	ADJ
aiua-10985	108	30	prostatic	prostatic	ADJ
aiua-10985	108	31	hyperplasia	hyperplasia	NOUN
aiua-10985	108	32	and	and	CCONJ
aiua-10985	108	33	an	an	DET
aiua-10985	108	34	enlarged	enlarged	ADJ
aiua-10985	108	35	prostate	prostate	NOUN
aiua-10985	108	36	:	:	PUNCT
aiua-10985	108	37	2	2	NUM
aiua-10985	108	38	-	-	PUNCT
aiua-10985	108	39	year	year	NOUN
aiua-10985	108	40	data	datum	NOUN
aiua-10985	108	41	from	from	ADP
aiua-10985	108	42	the	the	DET
aiua-10985	108	43	combat	combat	NOUN
aiua-10985	108	44	study	study	NOUN
aiua-10985	108	45	.	.	PUNCT
aiua-10985	109	1	eur	eur	PROPN
aiua-10985	109	2	urol	urol	PROPN
aiua-10985	109	3	.	.	PUNCT
aiua-10985	109	4	2009	2009	NUM
aiua-10985	109	5	;	;	PUNCT
aiua-10985	109	6	55:461	55:461	NUM
aiua-10985	109	7	-	-	SYM
aiua-10985	109	8	471	471	NUM
aiua-10985	109	9	.	.	NOUN
aiua-10985	110	1	5	5	NUM
aiua-10985	110	2	.	.	PUNCT
aiua-10985	110	3	roehrborn	roehrborn	ADJ
aiua-10985	110	4	cg	cg	NOUN
aiua-10985	110	5	,	,	PUNCT
aiua-10985	110	6	siami	siami	VERB
aiua-10985	110	7	p	p	NOUN
aiua-10985	110	8	,	,	PUNCT
aiua-10985	110	9	barkin	barkin	PROPN
aiua-10985	110	10	j	j	PROPN
aiua-10985	110	11	,	,	PUNCT
aiua-10985	110	12	et	et	PROPN
aiua-10985	110	13	al	al	PROPN
aiua-10985	110	14	.	.	PUNCT
aiua-10985	111	1	combat	combat	PROPN
aiua-10985	111	2	study	study	NOUN
aiua-10985	111	3	group	group	NOUN
aiua-10985	111	4	:	:	PUNCT
aiua-10985	111	5	the	the	DET
aiua-10985	111	6	effects	effect	NOUN
aiua-10985	111	7	of	of	ADP
aiua-10985	111	8	combination	combination	NOUN
aiua-10985	111	9	therapy	therapy	NOUN
aiua-10985	111	10	with	with	ADP
aiua-10985	111	11	dutasteride	dutasteride	NOUN
aiua-10985	111	12	and	and	CCONJ
aiua-10985	111	13	tamsulosin	tamsulosin	VERB
aiua-10985	111	14	on	on	ADP
aiua-10985	111	15	clinical	clinical	ADJ
aiua-10985	111	16	outcomes	outcome	NOUN
aiua-10985	111	17	in	in	ADP
aiua-10985	111	18	men	man	NOUN
aiua-10985	111	19	with	with	ADP
aiua-10985	111	20	symptomatic	symptomatic	ADJ
aiua-10985	111	21	benign	benign	ADJ
aiua-10985	111	22	prostatic	prostatic	ADJ
aiua-10985	111	23	hyperplasia	hyperplasia	NOUN
aiua-10985	111	24	:	:	PUNCT
aiua-10985	111	25	4	4	NUM
aiua-10985	111	26	-	-	PUNCT
aiua-10985	111	27	year	year	NOUN
aiua-10985	111	28	results	result	NOUN
aiua-10985	111	29	from	from	ADP
aiua-10985	111	30	the	the	DET
aiua-10985	111	31	combat	combat	NOUN
aiua-10985	111	32	study	study	NOUN
aiua-10985	111	33	.	.	PUNCT
aiua-10985	112	1	eur	eur	PROPN
aiua-10985	112	2	urol	urol	PROPN
aiua-10985	112	3	.	.	PUNCT
aiua-10985	113	1	2010	2010	NUM
aiua-10985	113	2	;	;	PUNCT
aiua-10985	113	3	57:123	57:123	NUM
aiua-10985	113	4	-	-	SYM
aiua-10985	113	5	131	131	NUM
aiua-10985	113	6	.	.	NOUN
aiua-10985	114	1	6	6	NUM
aiua-10985	114	2	.	.	X
aiua-10985	115	1	rothschild	rothschild	PROPN
aiua-10985	115	2	jm	jm	PROPN
aiua-10985	115	3	,	,	PUNCT
aiua-10985	115	4	bastes	baste	VERB
aiua-10985	115	5	dw	dw	PROPN
aiua-10985	115	6	,	,	PUNCT
aiua-10985	115	7	leape	leape	NOUN
aiua-10985	115	8	ll	ll	NOUN
aiua-10985	115	9	.	.	PUNCT
aiua-10985	116	1	preventable	preventable	ADJ
aiua-10985	116	2	medical	medical	ADJ
aiua-10985	116	3	injuries	injury	NOUN
aiua-10985	116	4	in	in	ADP
aiua-10985	116	5	older	old	ADJ
aiua-10985	116	6	patient	patient	NOUN
aiua-10985	116	7	.	.	PUNCT
aiua-10985	117	1	arch	arch	ADJ
aiua-10985	117	2	intern	intern	PROPN
aiua-10985	117	3	med	med	PROPN
aiua-10985	117	4	.	.	PROPN
aiua-10985	117	5	2000	2000	NUM
aiua-10985	118	1	;	;	PUNCT
aiua-10985	118	2	160:2717	160:2717	NUM
aiua-10985	118	3	-	-	PUNCT
aiua-10985	118	4	2728	2728	NUM
aiua-10985	118	5	.	.	PUNCT
aiua-10985	119	1	7	7	X
aiua-10985	119	2	.	.	X
aiua-10985	119	3	suzuki	suzuki	PROPN
aiua-10985	119	4	y	y	PROPN
aiua-10985	119	5	,	,	PUNCT
aiua-10985	119	6	akishita	akishita	PROPN
aiua-10985	119	7	m	m	PROPN
aiua-10985	119	8	,	,	PUNCT
aiua-10985	119	9	arai	arai	PROPN
aiua-10985	119	10	h	h	NOUN
aiua-10985	119	11	,	,	PUNCT
aiua-10985	119	12	et	et	PROPN
aiua-10985	119	13	al	al	PROPN
aiua-10985	119	14	.	.	PUNCT
aiua-10985	119	15	multiple	multiple	ADJ
aiua-10985	119	16	consultations	consultation	NOUN
aiua-10985	119	17	and	and	CCONJ
aiua-10985	119	18	polypharmacy	polypharmacy	NOUN
aiua-10985	119	19	of	of	ADP
aiua-10985	119	20	patients	patient	NOUN
aiua-10985	119	21	attending	attend	VERB
aiua-10985	119	22	geriatric	geriatric	ADJ
aiua-10985	119	23	outpatient	outpatient	NOUN
aiua-10985	119	24	units	unit	NOUN
aiua-10985	119	25	of	of	ADP
aiua-10985	119	26	university	university	NOUN
aiua-10985	119	27	hospitals	hospital	NOUN
aiua-10985	119	28	.	.	PUNCT
aiua-10985	120	1	geriatr	geriatr	ADJ
aiua-10985	120	2	gerontol	gerontol	ADJ
aiua-10985	120	3	int	int	NOUN
aiua-10985	120	4	.	.	PUNCT
aiua-10985	121	1	2006	2006	NUM
aiua-10985	121	2	;	;	PUNCT
aiua-10985	121	3	6:244	6:244	NOUN
aiua-10985	121	4	-	-	SYM
aiua-10985	121	5	247	247	NUM
aiua-10985	121	6	.	.	NOUN
aiua-10985	122	1	8	8	NUM
aiua-10985	122	2	.	.	PUNCT
aiua-10985	123	1	kojima	kojima	PROPN
aiua-10985	123	2	t	t	PROPN
aiua-10985	123	3	,	,	PUNCT
aiua-10985	123	4	akishita	akishita	PROPN
aiua-10985	123	5	m	m	PROPN
aiua-10985	123	6	,	,	PUNCT
aiua-10985	123	7	kameyama	kameyama	PROPN
aiua-10985	124	1	y	y	PROPN
aiua-10985	124	2	,	,	PUNCT
aiua-10985	124	3	et	et	PROPN
aiua-10985	124	4	al	al	PROPN
aiua-10985	124	5	.	.	PROPN
aiua-10985	124	6	high	high	ADJ
aiua-10985	124	7	risk	risk	NOUN
aiua-10985	124	8	of	of	ADP
aiua-10985	124	9	adverse	adverse	ADJ
aiua-10985	124	10	drug	drug	NOUN
aiua-10985	124	11	reactions	reaction	NOUN
aiua-10985	124	12	in	in	ADP
aiua-10985	124	13	elderly	elderly	ADJ
aiua-10985	124	14	patients	patient	NOUN
aiua-10985	124	15	taking	take	VERB
aiua-10985	124	16	six	six	NUM
aiua-10985	124	17	or	or	CCONJ
aiua-10985	124	18	more	more	ADJ
aiua-10985	124	19	drugs	drug	NOUN
aiua-10985	124	20	:	:	PUNCT
aiua-10985	124	21	analysis	analysis	NOUN
aiua-10985	124	22	of	of	ADP
aiua-10985	124	23	inpatient	inpatient	NOUN
aiua-10985	124	24	database	database	NOUN
aiua-10985	124	25	.	.	PUNCT
aiua-10985	125	1	geriatr	geriatr	ADJ
aiua-10985	125	2	gerontol	gerontol	ADJ
aiua-10985	125	3	int	int	NOUN
aiua-10985	125	4	.	.	PUNCT
aiua-10985	126	1	2012	2012	NUM
aiua-10985	126	2	;	;	PUNCT
aiua-10985	126	3	12:761	12:761	NUM
aiua-10985	126	4	-	-	SYM
aiua-10985	126	5	762	762	NUM
aiua-10985	126	6	.	.	NOUN
aiua-10985	127	1	9	9	NUM
aiua-10985	127	2	.	.	PUNCT
aiua-10985	128	1	kojima	kojima	PROPN
aiua-10985	128	2	t	t	PROPN
aiua-10985	128	3	,	,	PUNCT
aiua-10985	128	4	akishita	akishita	PROPN
aiua-10985	128	5	m	m	PROPN
aiua-10985	128	6	,	,	PUNCT
aiua-10985	128	7	nakamura	nakamura	PROPN
aiua-10985	128	8	t	t	PROPN
aiua-10985	128	9	,	,	PUNCT
aiua-10985	128	10	et	et	PROPN
aiua-10985	128	11	al	al	PROPN
aiua-10985	128	12	.	.	PUNCT
aiua-10985	128	13	polypharmacy	polypharmacy	PROPN
aiua-10985	128	14	as	as	ADP
aiua-10985	128	15	a	a	DET
aiua-10985	128	16	risk	risk	NOUN
aiua-10985	128	17	for	for	ADP
aiua-10985	128	18	fall	fall	NOUN
aiua-10985	128	19	occurrence	occurrence	NOUN
aiua-10985	128	20	.	.	PUNCT
aiua-10985	129	1	geriatr	geriatr	ADJ
aiua-10985	129	2	gerontol	gerontol	ADJ
aiua-10985	129	3	int	int	NOUN
aiua-10985	129	4	.	.	PUNCT
aiua-10985	130	1	2012	2012	NUM
aiua-10985	130	2	;	;	PUNCT
aiua-10985	130	3	12:425	12:425	NUM
aiua-10985	130	4	-	-	SYM
aiua-10985	130	5	430	430	NUM
aiua-10985	130	6	.	.	PUNCT
aiua-10985	131	1	10	10	NUM
aiua-10985	131	2	.	.	PUNCT
aiua-10985	132	1	barkin	barkin	PROPN
aiua-10985	132	2	j	j	PROPN
aiua-10985	132	3	,	,	PUNCT
aiua-10985	132	4	guimaraces	guimarace	NOUN
aiua-10985	132	5	m	m	PROPN
aiua-10985	132	6	,	,	PUNCT
aiua-10985	132	7	jacobi	jacobi	PROPN
aiua-10985	132	8	g	g	PROPN
aiua-10985	132	9	,	,	PUNCT
aiua-10985	132	10	et	et	PROPN
aiua-10985	132	11	al	al	PROPN
aiua-10985	132	12	.	.	PUNCT
aiua-10985	132	13	alpha	alpha	PROPN
aiua-10985	132	14	-	-	PUNCT
aiua-10985	132	15	blocker	blocker	NOUN
aiua-10985	132	16	therapy	therapy	NOUN
aiua-10985	132	17	can	can	AUX
aiua-10985	132	18	be	be	AUX
aiua-10985	132	19	withdrawn	withdraw	VERB
aiua-10985	132	20	in	in	ADP
aiua-10985	132	21	the	the	DET
aiua-10985	132	22	majority	majority	NOUN
aiua-10985	132	23	of	of	ADP
aiua-10985	132	24	men	man	NOUN
aiua-10985	132	25	following	follow	VERB
aiua-10985	132	26	initial	initial	ADJ
aiua-10985	132	27	combination	combination	NOUN
aiua-10985	132	28	therapy	therapy	NOUN
aiua-10985	132	29	with	with	ADP
aiua-10985	132	30	the	the	DET
aiua-10985	132	31	dual	dual	ADJ
aiua-10985	132	32	5alpha	5alpha	NUM
aiua-10985	132	33	-	-	PUNCT
aiua-10985	132	34	reductase	reductase	NOUN
aiua-10985	132	35	inhibitor	inhibitor	NOUN
aiua-10985	132	36	dutasteride	dutasteride	NOUN
aiua-10985	132	37	.	.	PUNCT
aiua-10985	133	1	eur	eur	PROPN
aiua-10985	133	2	urol	urol	PROPN
aiua-10985	133	3	.	.	PUNCT
aiua-10985	134	1	2003	2003	NUM
aiua-10985	134	2	;	;	PUNCT
aiua-10985	134	3	44:461	44:461	NUM
aiua-10985	134	4	-	-	SYM
aiua-10985	134	5	466	466	NUM
aiua-10985	134	6	.	.	PUNCT
aiua-10985	135	1	11	11	NUM
aiua-10985	135	2	.	.	PUNCT
aiua-10985	136	1	shindo	shindo	PROPN
aiua-10985	136	2	t	t	PROPN
aiua-10985	136	3	,	,	PUNCT
aiua-10985	136	4	hashimoto	hashimoto	NOUN
aiua-10985	136	5	k	k	PROPN
aiua-10985	136	6	,	,	PUNCT
aiua-10985	136	7	shimizu	shimizu	PROPN
aiua-10985	136	8	t	t	PROPN
aiua-10985	136	9	,	,	PUNCT
aiua-10985	136	10	et	et	PROPN
aiua-10985	136	11	al	al	PROPN
aiua-10985	136	12	.	.	PROPN
aiua-10985	136	13	significance	significance	NOUN
aiua-10985	136	14	of	of	ADP
aiua-10985	136	15	intraprostatic	intraprostatic	ADJ
aiua-10985	136	16	architecture	architecture	NOUN
aiua-10985	136	17	and	and	CCONJ
aiua-10985	136	18	regrowth	regrowth	VERB
aiua-10985	136	19	velocity	velocity	NOUN
aiua-10985	136	20	for	for	ADP
aiua-10985	136	21	considering	consider	VERB
aiua-10985	136	22	discontinuation	discontinuation	NOUN
aiua-10985	136	23	of	of	ADP
aiua-10985	136	24	dutasteride	dutasteride	NOUN
aiua-10985	136	25	after	after	ADP
aiua-10985	136	26	combination	combination	NOUN
aiua-10985	136	27	therapy	therapy	NOUN
aiua-10985	136	28	with	with	ADP
aiua-10985	136	29	an	an	DET
aiua-10985	136	30	alpha	alpha	NOUN
aiua-10985	136	31	blocker	blocker	NOUN
aiua-10985	136	32	:	:	PUNCT
aiua-10985	136	33	a	a	DET
aiua-10985	136	34	prospective	prospective	ADJ
aiua-10985	136	35	,	,	PUNCT
aiua-10985	136	36	pilot	pilot	NOUN
aiua-10985	136	37	study	study	NOUN
aiua-10985	136	38	.	.	PUNCT
aiua-10985	137	1	kju	kju	PROPN
aiua-10985	137	2	.	.	PROPN
aiua-10985	137	3	2015	2015	NUM
aiua-10985	137	4	;	;	PUNCT
aiua-10985	138	1	56:305	56:305	NUM
aiua-10985	138	2	-	-	SYM
aiua-10985	138	3	309	309	NUM
aiua-10985	138	4	.	.	PUNCT
aiua-10985	139	1	12	12	NUM
aiua-10985	139	2	.	.	PUNCT
aiua-10985	139	3	welk	welk	PROPN
aiua-10985	139	4	b	b	PROPN
aiua-10985	139	5	,	,	PUNCT
aiua-10985	139	6	mcarthur	mcarthur	PROPN
aiua-10985	139	7	e	e	PROPN
aiua-10985	139	8	,	,	PUNCT
aiua-10985	139	9	ordon	ordon	PROPN
aiua-10985	139	10	m	m	PROPN
aiua-10985	139	11	,	,	PUNCT
aiua-10985	139	12	et	et	PROPN
aiua-10985	139	13	al	al	PROPN
aiua-10985	139	14	,	,	PUNCT
aiua-10985	139	15	association	association	NOUN
aiua-10985	139	16	of	of	ADP
aiua-10985	139	17	suicidality	suicidality	NOUN
aiua-10985	139	18	and	and	CCONJ
aiua-10985	139	19	depression	depression	NOUN
aiua-10985	139	20	with	with	ADP
aiua-10985	139	21	5alpha	5alpha	NUM
aiua-10985	139	22	-	-	PUNCT
aiua-10985	139	23	reductase	reductase	NOUN
aiua-10985	139	24	inhibitors	inhibitor	NOUN
aiua-10985	139	25	.	.	PUNCT
aiua-10985	140	1	jama	jama	PROPN
aiua-10985	140	2	intern	intern	PROPN
aiua-10985	140	3	med	med	PROPN
aiua-10985	140	4	.	.	PROPN
aiua-10985	141	1	2017	2017	NUM
aiua-10985	141	2	;	;	PUNCT
aiua-10985	141	3	177:683	177:683	NUM
aiua-10985	141	4	-	-	SYM
aiua-10985	141	5	691	691	NUM
aiua-10985	141	6	.	.	PUNCT
aiua-10985	142	1	13	13	NUM
aiua-10985	142	2	.	.	PUNCT
aiua-10985	143	1	lin	lin	PROPN
aiua-10985	143	2	vc	vc	PROPN
aiua-10985	143	3	,	,	PUNCT
aiua-10985	143	4	liao	liao	PROPN
aiua-10985	143	5	ch	ch	PROPN
aiua-10985	143	6	,	,	PUNCT
aiua-10985	143	7	kuo	kuo	PROPN
aiua-10985	143	8	hc	hc	PROPN
aiua-10985	143	9	.	.	PROPN
aiua-10985	143	10	progression	progression	NOUN
aiua-10985	143	11	of	of	ADP
aiua-10985	143	12	lower	low	ADJ
aiua-10985	143	13	urinary	urinary	ADJ
aiua-10985	143	14	tract	tract	NOUN
aiua-10985	143	15	symptoms	symptom	NOUN
aiua-10985	143	16	after	after	ADP
aiua-10985	143	17	discontinuation	discontinuation	NOUN
aiua-10985	143	18	of	of	ADP
aiua-10985	143	19	1	1	NUM
aiua-10985	143	20	medication	medication	NOUN
aiua-10985	143	21	from	from	ADP
aiua-10985	143	22	2	2	NUM
aiua-10985	143	23	-	-	PUNCT
aiua-10985	143	24	year	year	NOUN
aiua-10985	143	25	combined	combine	VERB
aiua-10985	143	26	alphablocker	alphablocker	NOUN
aiua-10985	143	27	and	and	CCONJ
aiua-10985	143	28	5	5	NUM
aiua-10985	143	29	-	-	PUNCT
aiua-10985	143	30	alpha	alpha	NOUN
aiua-10985	143	31	-	-	PUNCT
aiua-10985	143	32	reductase	reductase	NOUN
aiua-10985	143	33	inhibitor	inhibitor	NOUN
aiua-10985	143	34	therapy	therapy	NOUN
aiua-10985	143	35	for	for	ADP
aiua-10985	143	36	benign	benign	ADJ
aiua-10985	143	37	prostatic	prostatic	ADJ
aiua-10985	143	38	hyperplasia	hyperplasia	NOUN
aiua-10985	143	39	in	in	ADP
aiua-10985	143	40	men	man	NOUN
aiua-10985	143	41	--	--	PUNCT
aiua-10985	143	42	a	a	DET
aiua-10985	143	43	randomized	randomized	ADJ
aiua-10985	143	44	multicenter	multicenter	NOUN
aiua-10985	143	45	study	study	NOUN
aiua-10985	143	46	.	.	PUNCT
aiua-10985	144	1	urology	urology	NOUN
aiua-10985	144	2	.	.	PUNCT
aiua-10985	145	1	2014	2014	NUM
aiua-10985	145	2	;	;	PUNCT
aiua-10985	145	3	83:416	83:416	NUM
aiua-10985	145	4	-	-	SYM
aiua-10985	145	5	421	421	NUM
aiua-10985	145	6	.	.	PUNCT
aiua-10985	146	1	14	14	NUM
aiua-10985	146	2	.	.	PUNCT
aiua-10985	147	1	jeong	jeong	PROPN
aiua-10985	147	2	yb	yb	PROPN
aiua-10985	147	3	,	,	PUNCT
aiua-10985	147	4	kwon	kwon	VERB
aiua-10985	147	5	ks	ks	PROPN
aiua-10985	147	6	,	,	PUNCT
aiua-10985	147	7	kim	kim	PROPN
aiua-10985	147	8	sd	sd	PROPN
aiua-10985	147	9	,	,	PUNCT
aiua-10985	147	10	kim	kim	PROPN
aiua-10985	147	11	hj	hj	PROPN
aiua-10985	147	12	.	.	PROPN
aiua-10985	148	1	effect	effect	NOUN
aiua-10985	148	2	of	of	ADP
aiua-10985	148	3	discontinuation	discontinuation	NOUN
aiua-10985	148	4	of	of	ADP
aiua-10985	148	5	5alpha	5alpha	NUM
aiua-10985	148	6	-	-	PUNCT
aiua-10985	148	7	reductase	reductase	NOUN
aiua-10985	148	8	inhibitors	inhibitor	NOUN
aiua-10985	148	9	on	on	ADP
aiua-10985	148	10	prostate	prostate	NOUN
aiua-10985	148	11	volume	volume	NOUN
aiua-10985	148	12	and	and	CCONJ
aiua-10985	148	13	symptoms	symptom	NOUN
aiua-10985	148	14	in	in	ADP
aiua-10985	148	15	men	man	NOUN
aiua-10985	148	16	with	with	ADP
aiua-10985	148	17	bph	bph	NOUN
aiua-10985	148	18	:	:	PUNCT
aiua-10985	148	19	a	a	DET
aiua-10985	148	20	prospective	prospective	ADJ
aiua-10985	148	21	study	study	NOUN
aiua-10985	148	22	.	.	PUNCT
aiua-10985	149	1	urology	urology	NOUN
aiua-10985	149	2	.	.	PUNCT
aiua-10985	150	1	2009	2009	NUM
aiua-10985	150	2	;	;	PUNCT
aiua-10985	150	3	73:802	73:802	NUM
aiua-10985	150	4	-	-	SYM
aiua-10985	150	5	806	806	NUM
aiua-10985	150	6	.	.	PUNCT
aiua-10985	151	1	15	15	NUM
aiua-10985	151	2	.	.	PUNCT
aiua-10985	152	1	nørgaard	nørgaard	PROPN
aiua-10985	152	2	m	m	PROPN
aiua-10985	152	3	,	,	PUNCT
aiua-10985	152	4	horváth	horváth	PROPN
aiua-10985	152	5	-	-	PUNCT
aiua-10985	152	6	puhó	puhó	PROPN
aiua-10985	152	7	e	e	NOUN
aiua-10985	152	8	,	,	PUNCT
aiua-10985	152	9	corraini	corraini	NOUN
aiua-10985	152	10	p	p	NOUN
aiua-10985	152	11	,	,	PUNCT
aiua-10985	152	12	et	et	PROPN
aiua-10985	152	13	al	al	PROPN
aiua-10985	152	14	.	.	PUNCT
aiua-10985	153	1	sleep	sleep	VERB
aiua-10985	153	2	disruption	disruption	NOUN
aiua-10985	153	3	and	and	CCONJ
aiua-10985	153	4	alzheimer	alzheimer	PROPN
aiua-10985	153	5	's	's	PART
aiua-10985	153	6	disease	disease	NOUN
aiua-10985	153	7	risk	risk	NOUN
aiua-10985	153	8	:	:	PUNCT
aiua-10985	153	9	inferences	inference	NOUN
aiua-10985	153	10	from	from	ADP
aiua-10985	153	11	men	man	NOUN
aiua-10985	153	12	with	with	ADP
aiua-10985	153	13	benign	benign	ADJ
aiua-10985	153	14	prostatic	prostatic	ADJ
aiua-10985	153	15	hyperplasia	hyperplasia	NOUN
aiua-10985	153	16	.	.	PUNCT
aiua-10985	154	1	eclinical	eclinical	ADJ
aiua-10985	154	2	medicine	medicine	NOUN
aiua-10985	154	3	.	.	PUNCT
aiua-10985	155	1	2021	2021	NUM
aiua-10985	155	2	;	;	PUNCT
aiua-10985	156	1	32:100740	32:100740	X
aiua-10985	156	2	.	.	PUNCT
aiua-10985	157	1	correspondence	correspondence	PROPN
aiua-10985	157	2	hiroshi	hiroshi	PROPN
aiua-10985	157	3	masuda	masuda	PROPN
aiua-10985	157	4	,	,	PUNCT
aiua-10985	157	5	md	md	PROPN
aiua-10985	157	6	,	,	PUNCT
aiua-10985	157	7	phd	phd	NOUN
aiua-10985	157	8	(	(	PUNCT
aiua-10985	157	9	corresponding	correspond	VERB
aiua-10985	157	10	author	author	NOUN
aiua-10985	157	11	)	)	PUNCT
aiua-10985	157	12	hrsmasuda@yahoo.co.jp	hrsmasuda@yahoo.co.jp	PROPN
aiua-10985	157	13	kosuke	kosuke	PROPN
aiua-10985	157	14	mikami	mikami	PROPN
aiua-10985	157	15	,	,	PUNCT
aiua-10985	157	16	md	md	PROPN
aiua-10985	157	17	kotaro	kotaro	PROPN
aiua-10985	157	18	otsuka	otsuka	PROPN
aiua-10985	157	19	,	,	PUNCT
aiua-10985	157	20	md	md	PROPN
aiua-10985	157	21	kyokusin	kyokusin	PROPN
aiua-10985	157	22	hou	hou	PROPN
aiua-10985	157	23	,	,	PUNCT
aiua-10985	157	24	md	md	PROPN
aiua-10985	157	25	takahito	takahito	PROPN
aiua-10985	157	26	suyama	suyama	PROPN
aiua-10985	157	27	,	,	PUNCT
aiua-10985	157	28	md	md	PROPN
aiua-10985	157	29	kazuhiro	kazuhiro	PROPN
aiua-10985	157	30	araki	araki	PROPN
aiua-10985	157	31	,	,	PUNCT
aiua-10985	157	32	md	md	PROPN
aiua-10985	157	33	satoko	satoko	PROPN
aiua-10985	157	34	kojima	kojima	PROPN
aiua-10985	157	35	,	,	PUNCT
aiua-10985	157	36	md	md	PROPN
aiua-10985	157	37	yukio	yukio	PROPN
aiua-10985	157	38	naya	naya	PROPN
aiua-10985	157	39	,	,	PUNCT
aiua-10985	157	40	md	md	PROPN
aiua-10985	157	41	department	department	PROPN
aiua-10985	157	42	of	of	ADP
aiua-10985	157	43	urology	urology	NOUN
aiua-10985	157	44	,	,	PUNCT
aiua-10985	157	45	teikyo	teikyo	PROPN
aiua-10985	157	46	university	university	PROPN
aiua-10985	157	47	chiba	chiba	PROPN
aiua-10985	157	48	medical	medical	PROPN
aiua-10985	157	49	center	center	PROPN
aiua-10985	157	50	3426	3426	NUM
aiua-10985	157	51	-	-	SYM
aiua-10985	157	52	3	3	NUM
aiua-10985	157	53	anesaki	anesaki	NOUN
aiua-10985	157	54	,	,	PUNCT
aiua-10985	157	55	ichihara	ichihara	PROPN
aiua-10985	157	56	,	,	PUNCT
aiua-10985	157	57	chiba	chiba	PROPN
aiua-10985	157	58	,	,	PUNCT
aiua-10985	157	59	299	299	NUM
aiua-10985	157	60	-	-	SYM
aiua-10985	157	61	0111	0111	NUM
aiua-10985	157	62	(	(	PUNCT
aiua-10985	157	63	japan	japan	PROPN
aiua-10985	157	64	)	)	PUNCT